Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 58
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Abnormal copper coordination obtained by a TiO2 overlayer as the key to enhance photocatalytic hydrogen generation

  • Quach, Vien-Duong|||0000-0002-1968-9253
  • Spadaro, Maria Chiara|||0000-0002-6540-0377
  • Dragoe, Diana
  • Botifoll, Marc|||0000-0002-4876-6393
  • Vezin, Hervé
  • Colbeau-Justin, Christophe|||0000-0003-2343-5878
  • Dumeignil, Franck|||0000-0001-9727-8196
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Wojcieszak, Robert|||0000-0002-8956-5846
  • Ghazzal, Mohamed Nawfal|||0000-0002-2040-995X
Strong metal-support interaction (SMSI) is a pivotal strategy in thermal catalysis; however, its application in photocatalysis leaves ample area for further development. A method inducing SMSI between earth-abundant metals, such as copper and TiO, at room temperature, and thus hindering the agglomeration of copper species remains rarely reported. In this work, we achieved SMSI construction of TiO overlayers on Cu nanoparticles via a straightforward soft-chemistry method. SMSI coverage is stable even after high-temperature treatment in the air (500 °C), as demonstrated by chemical mapping and surface analysis. The method is more accurate than thermal reduction since it produces a metastable, highly active anatase phase. Interestingly, the TiO overlayer induces the formation of four-coordinated copper(ii) species surrounded by oxygen atoms, resulting in coexisting CuO planes, which were monitored through high-resolution transmission electron microscopy and electron paramagnetic resonance spectroscopy. The stronger interfacial interaction by forming Ti-O-Cu bonding promotes charge carrier separation, producing twice as much H than the low interfacial interaction within a conventional photoactive system wherein copper was decorated onto TiO. Our approach offers a rational design for SMSI materials in photocatalysis, which is extendable to other catalytic reactions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Enhanced Electrochemical Hydrogenation of Benzaldehyde to Benzyl Alcohol on Pd@Ni-MOF by Modifying the Adsorption Configuration

  • Gong, Li
  • Zhang, Chao Yue
  • Li, Junshan|||0000-0002-1482-1972
  • Montaña-Mora, Guillem|||0000-0003-1208-6836
  • Botifoll, Marc|||0000-0002-4876-6393
  • Guo, Tiezhu
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Zhou, Jin Yuan
  • Kallio, Tanja|||0000-0001-6671-8582
  • Martínez-Alanis, Paulina R.|||0000-0003-3675-4472
  • Cabot i Codina, Andreu|||0000-0002-7533-3251
Electrocatalytic hydrogenation (ECH) approaches under ambient temperature and pressure offer significant potential advantages over thermal hydrogenation processes but require highly active and efficient hydrogenation electrocatalysts. The performance of such hydrogenation electrocatalysts strongly depends not only on the active phase but also on the architecture and surface chemistry of the support material. Herein, Pd nanoparticles supported on a nickel metal-organic framework (MOF), Ni-MOF-74, are prepared, and their activity toward the ECH of benzaldehyde (BZH) in a 3 M acetate (pH 5.2) aqueous electrolyte is explored. An outstanding ECH rate up to 283 μmol cm h with a Faradaic efficiency (FE) of 76% is reached. Besides, higher FEs of up to 96% are achieved using a step-function voltage. Materials Studio and density functional theory calculations show these outstanding performances to be associated with the Ni-MOF support that promotes H-bond formation, facilitates water desorption, and induces favorable tilted BZH adsorption on the surface of the Pd nanoparticles. In this configuration, BZH is bonded to the Pd surface by the carbonyl group rather than through the aromatic ring, thus reducing the energy barriers of the elemental reaction steps and increasing the overall reaction efficiency.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown. We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ/Aβ ratio. Plasma pTau, pTau, Aβ and Aβ were measured in the fully-automated LUMIPULSE platform. We used linear regression to compare plasma biomarkers concentrations between A + and A- groups, evaluated Spearman's correlation between plasma and CSF and performed ROC analyses to assess their diagnostic accuracy to detect brain amyloidosis as determined by CSF Aβ/Aβ ratio. We analyzed the potential of pTau to predict amyloidosis in CSF. Plasma pTau and pTau concentration were higher in A + than A- while the plasma Aβ/Aβ ratio was lower in A + compared to A-. pTau and the Aβ/Aβ ratio showed moderate correlation between plasma and CSF (Rho = 0.66 and 0.69, respectively). The areas under the ROC curve to discriminate A + from A- participants were 0.94 (95% CI 0.92-0.97) for pTau, and 0.88 (95% CI 0.84-0.92) for both pTau and Aβ/Aβ. Chronic kidney disease (CKD) was related to increased plasma biomarker concentrations, but ratios were less affected. Plasma pTau had the highest fold change (x4.2) and showed high predictive capability in discriminating A + from A-, having 4-7% misclassification rate. The global accuracy of plasma pTau using a two-threshold approach was robust in symptomatic groups, exceeding 90%. The evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau showed excellent diagnostic accuracy to identify participants with AD in a consecutive sample representing the routine clinical practice in a specialized memory unit.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

  • Verberk, I.M.W.
  • Jutte, J.
  • Kingma, M.Y.
  • Vigneswaran, S.
  • Gouda, M.M.T.E.E.
  • van Engelen, M.P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Chevalier, C.
  • Marizzoni, M.
  • van de Giessen, E.M.
  • Lemstra, A.W.
  • Pijnenburg, Y.A.L.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • den Braber, A.
  • Wilson, D.
  • Schut, M.C.
  • van Harten, A.C.
  • Teunissen, C.E.
INTRODUCTION: We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS: We measured the plasma biomarkers with Simoa (n = 1199), applied LASSO regression for biomarker selection and receiver operating characteristics (ROC) analyses to determine diagnostic accuracy. We validated our findings in two independent cohorts and constructed a visualization approach. RESULTS: P-tau181, GFAP, and NfL were selected. This combination had area under the curve (AUC) = 83% to identify amyloid positivity in pre-dementia stages, AUC = 87%-89% to differentiate Alzheimer's or controls from frontotemporal dementia, AUC = 74%-76% to differentiate Alzheimer's or controls from dementia with Lewy bodies. Highly reproducible AUCs were obtained in independent cohorts. The resulting visualization tool includes UpSet plots to visualize the stand-alone biomarker results and density plots to visualize the biomarker results combined. DISCUSSION: Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings. Highlights: We developed a multimarker blood test interpretation tool for clinical dementia practice. Our interpretation tool includes plasma biomarkers P-tau, GFAP, and NfL. Our tool is particularly useful for Alzheimer's and frontotemporal dementia diagnosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

  • Bolsewig, K.
  • Willemse, E.A.J.
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Rábano, Alberto|||0000-0001-9320-6566
  • Martínez, Minerva|||0000-0002-9036-2595
  • Doecke, J.D.|||0000-0003-2863-0293
  • Bellomo, Giovanni|||0000-0003-0456-5650
  • Vermunt, L.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Halbgebauer, S.
  • in 't Veld, S.
  • Mattsson-Carlgren, N.
  • Veverova, K.
  • Fowler, C.J.
  • Boonkamp, L.
  • Koel-Simmelink, M.
  • Hussainali, Z.
  • Ruiters, D.N.
  • Gaetani, L.
  • Toja, A.
  • Fortea, Juan|||0000-0002-1340-638X
  • Pijnenburg, Y.
  • Lemstra, A.W.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Hort, J.
  • Otto, M.|||0000-0003-4273-4267
  • Hansson, Oskar|||0000-0001-8467-7286
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Masters, C.L.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Teunissen, C.E.
  • Campo Milán, Marta del|||0000-0003-2808-3699
DOPA Decarboxylase (DDC) has been proposed as a cerebrospinal fluid (CSF) biomarker with increased concentrations in Lewy body disorders (LBDs) and highest levels in patients receiving dopaminergic treatment. Here we evaluate plasma DDC, measured by proximity extension assay, and the effect of dopaminergic treatment in three independent LBD (with a focus on dementia with Lewy bodies (DLB) and Parkinson's disease (PD)) cohorts: an autopsy-confirmed cohort (n = 71), a large multicenter, cross-dementia cohort (n = 1498) and a longitudinal cohort with detailed treatment information (n = 66, median follow-up time[IQR] = 4[4, 4] years). Plasma DDC was not altered between different LBDs and other disease groups or controls in absence of treatment. DDC levels increased over time in PD, being significantly associated to higher dosages of dopaminergic treatment. This emphasizes the need to consider treatment effect when analyzing plasma DDC, and suggests that plasma DDC, in contrast to CSF DDC, is of limited use as a diagnostic biomarker for LBD, but could be valuable for treatment monitoring.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Strong charge-photon coupling in planar germanium enabled by granular aluminium superinductors

  • Janík, Marián
  • Roux, Kevin|||0000-0003-4832-7726
  • Borja-Espinosa, Carla
  • Sagi, Oliver
  • Baghdadi, Abdulhamid
  • Adletzberger, Thomas
  • Calcaterra, Stefano
  • Botifoll, Marc|||0000-0002-4876-6393
  • Garzón Manjón, Alba|||0000-0003-2954-1102
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Chrastina, Daniel|||0000-0002-1054-3717
  • Isella, Giovanni|||0000-0001-5951-7440
  • Pop, Ioan|||0000-0002-6776-9792
  • Katsaros, Georgios|||0000-0001-8342-202X
High kinetic inductance superconductors are gaining increasing interest for the realisation of qubits, amplifiers and detectors. Moreover, thanks to their high impedance, quantum buses made of such materials enable large zero-point fluctuations of the voltage, boosting the coupling rates to spin and charge qubits. However, fully exploiting the potential of disordered or granular superconductors is challenging, as their inductance and, therefore, impedance at high values are difficult to control. Here, we report a reproducible fabrication of granular aluminium resonators by developing a wireless ohmmeter, which allows in situ measurements during film deposition and, therefore, control of the kinetic inductance of granular aluminium films. Reproducible fabrication of circuits with impedances (inductances) exceeding 13 kΩ (1 nH per square) is now possible. By integrating a 7.9 kΩ resonator with a germanium double quantum dot, we demonstrate strong charge-photon coupling with a rate of gc/2π = 566 ± 2 MHz. This broadly applicable method opens the path for novel qubits and high-fidelity, long-distance two-qubit gates.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

  • Delaby, Constance|||0000-0002-8606-6814
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Busto, G.
  • Gabelle, A.
  • Ayrignac, X.
  • Bennys, K.
  • Muiño, Elena|||0000-0001-5839-7328
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Pradeilles, N.
  • Bounasri, Shaima El
  • Torres Alcalá, Soraya|||0000-0002-7054-2046
  • Hirtz, C.
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Lehmann, Sylvain|||0000-0001-6117-562X
Background: Blood-based assays are expected to be integrated into clinical routines across various contexts, including Alzheimer's disease (AD). Vascular dementia (VaD), which is the second most common cause leading to dementia after AD, could also significantly benefit from this advancement. However, no informative fluid biomarker has been identified for VaD. Given the disruption of iron homeostasis in both AD and VaD, this study aims to characterize the potential of the iron-related hormone Hepcidin as a biomarker for these two conditions. We will compare its added value to established AT(N) blood biomarkers. Methods: Blood biomarkers (amyloid-composite, p-Tau, Neurofilament Light Chain [NfL] and Hepcidin) levels in blood were analyzed in two independent cohorts and compared between AD patients and non-AD individuals. Additionally, blood Hepcidin and NfL were evaluated in the contexts of VaD and CADASIL, with their relative diagnostic value assessed. Results: Blood Hepcidin and NfL do not significantly increase the AUC obtained with both p-Tau and amyloid composite in the context of AD. In contrast, AUC for VaD diagnosis is significantly higher when combining these two blood biomarkers compared to NfL alone. Hepcidin was not significantly modified in CADASIL patients compared to control subjects. Conclusion: Blood Hepcidin and NfL have limited interest in the clinical context of AD but determination of these biomarkers shows to be highly informative for the diagnosis of VaD. This result could have important implications for diagnosis and implementation of clinical trials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metagenomic survey reveals Volzhskoe tick virus in Hyalomma ticks for the first time in western Europe, North-Eastern Spain

  • Carrera Faja, Laura|||0000-0002-7714-0576
  • Jasso, Mariette Viladomat
  • Sarmiento Guardia, Iris
  • Cabrera Gumbau, Jordi Manuel|||0009-0007-3952-7589
  • Espunyes, Johan|||0000-0002-8692-1593
  • Martínez-Urtaza, Jaime|||0000-0001-6219-0418
  • Cabezón Ponsoda, Óscar|||0000-0001-7543-8371
Ticks are reservoirs and vectors of several emerging arboviruses, yet their associated virome remains poorly characterized. Using meta-transcriptomic sequencing, we surveyed Hyalomma marginatum and Rhipicephalus bursa ticks collected from areas with contrasting Crimean-Congo haemorrhagic fever virus (CCHFV) seroprevalence in wild ungulates in north-eastern Spain, a region with no reported CCHF cases in humans. While CCHFV RNA was not detected, we identified Volzhskoe tick virus (VTV), a recently described member of the class Bunyaviricetes, first identified in Russia, in H. marginatum from the Ports de Tortosa i Beseit Natural Park-making its first report of VTV in Western Europe. These findings suggest a broader distribution of VTV and raise important questions about its potential interactions with CCHFV, pathogenicity and host range. Moreover, our approach underscores the value of metagenomic surveillance for improving our understanding of tick-borne virus ecology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of amyloid-negative neuropsychological norms using GAMLSS

  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Estanga, Ainara|||0000-0002-6616-314X
  • Ecay-Torres, Mirian|||0000-0001-7170-6180
  • de Luis, C.L.
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Castellví, Magdalena|||0000-0001-8769-9288
  • Pozueta, A.
  • García-Martínez, M.
  • Gómez-Andrés, David|||0000-0001-5654-7791
  • Lage, Carmen|||0000-0003-1703-121X
  • López-Garcia, Sara
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Balasa, Mircea|||0000-0002-1795-4228
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Tainta, Mikel|||0000-0003-0624-1211
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Martinez-Lage, Pablo|||0000-0001-5404-9967
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
INTRODUCTION: Recent research has suggested increased sensitivity of Alzheimer's disease (AD)-negative neuropsychological norms; concurrently, generalized additive models for location, scale, and shape (GAMLSS) have emerged as a promising alternative to traditional norming approaches. Here, we developed amyloid β-negative (Aβ-) next-generation norms (NGN) for a comprehensive neuropsychological battery using GAMLSS. METHODS: We included N = 987 cognitively normal (CN) individuals from a Spanish multicenter study with extensive neuropsychological data and cerebrospinal fluid AD biomarker assessment. NGN were developed using GAMLSS based on the performance of n = 774 Aβ- CN individuals aged 30-90 years. RESULTS: Age-, education-, and sex-adjusted z-scores were obtained for 14 measures covering the main cognitive domains (memory, language, attention/executive, and visuospatial functions). A user-friendly calculator for the z-scores was made available in an open-access ShinyApp to facilitate their application. DISCUSSION: NGN may improve the detection of objective cognitive impairment in clinical and research settings. Highlights: Brain amyloid β (Aβ) is associated with poorer performance in cognitively normal individuals. We provide GAMLSS-based Aβ-negative norms for 14 neuropsychological measures. Age, education, and often sex significantly influence cognitive performance. An online calculator for the demographically adjusted z-scores is freely available.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Arriola-Infante, J.E.
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Background: Knowledge on the effect of analytical variability and storage conditions are essential for the successful implementation of plasma pTau in prospective settings. Aims: To investigate the performance of plasma pTau, measured in consecutive samples with LUMIPULSE, for detecting Alzheimer's disease in a prospective memory clinic setting, along with evaluating its pre-analytical and analytical stability. Methods: We prospectively measured pTau using the LUMIPULSE automated platform in consecutive patient plasma samples collected between May and November 2024 at the Sant Pau Memory Unit (Barcelona). A subset of participants also underwent paired lumbar puncture for CSF AD biomarkers. We compared biomarker concentrations under different short-term storage conditions (4ºC vs -20ºC) and different protocol pipelines, and assessed lot-to-lot variability. In the subset with available CSF biomarkers, logistic regression was used to evaluate the association between plasma pTau217 and the likelihood of a positive (A +) or a negative (A-) CSF amyloid status. Using ROC analysis, in this prospective cohort we evaluated the accuracy of previously established thresholds derived from historical samples. Results: We included 280 participants, divided into two groups: those with (n = 109) and without CSF data (n = 171). Among the subset with CSF, 48% were A +, with a plasma pTau fold-change of 4.5 × compared to A-. We found no differences in plasma pTau concentrations between either short-term storage conditions. The overall coefficients of analytical variation ranged from 1.8% to 3.2%. Plasma pTau concentrations were slightly higher in paired samples of the clinical protocol. Following a two-threshold approach, the need of confirmatory tests (grey zones) after measuring plasma pTau ranged between 45.9% and 18.3% using our previously reported strict or lenient cutoffs (overall accuracy 96.6% and 92.1%, respectively). Conclusions: The robust stability and low lot-to-lot variability of plasma pTau measurement in an automated platform result in high diagnostic performance of this biomarker in the prospective evaluation of patients in a memory clinic setting. These findings support its implementation into clinical routine, offering clinicians an accessible biomarker for AD diagnosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Background: Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown. Methods: We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A +) or negative (A-) according to CSF Aβ1-42/Aβ1-40 ratio. Plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 were measured in the fully-automated LUMIPULSE platform. We used linear regression to compare plasma biomarkers concentrations between A + and A- groups, evaluated Spearman's correlation between plasma and CSF and performed ROC analyses to assess their diagnostic accuracy to detect brain amyloidosis as determined by CSF Aβ1-42/Aβ1-40 ratio. We analyzed the concordance of pTau217 with CSF amyloidosis. Results: Plasma pTau217 and pTau181 concentration were higher in A + than A- while the plasma Aβ1-42/Aβ1-40 ratio was lower in A + compared to A-. pTau181 and the Aβ1-42/Aβ1-40 ratio showed moderate correlation between plasma and CSF (Rho = 0.66 and 0.69, respectively). The areas under the ROC curve to discriminate A + from A- participants were 0.94 (95% CI 0.92-0.97) for pTau217, and 0.88 (95% CI 0.84-0.92) for both pTau181 and Aβ1-42/Aβ1-40. Chronic kidney disease (CKD) was related to increased plasma biomarker concentrations, but ratios were less affected. Plasma pTau217 had the highest fold change (× 3.2) and showed high predictive capability in discriminating A + from A-, having 4-7% misclassification rate. The global accuracy of plasma pTau217 using a two-threshold approach was robust in symptomatic groups, exceeding 90%. Conclusion: The evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau217 showed excellent diagnostic accuracy to identify participants with AD in a consecutive sample representing the routine clinical practice in a specialized memory unit.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome

  • Zsadanyi, Sara E.|||0000-0002-2033-5989
  • Morcillo Nieto, Alejandra O.|||0000-0003-2202-3521
  • Aranha, Mateus|||0000-0001-9594-292X
  • Aragón, Irina
  • Arriola Infante, José Enrique|||0000-0002-3298-4601
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Montal, Victor|||0000-0002-5714-9282
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Benejam, Bessy|||0000-0002-6789-8615
  • Fernández, S.
  • Bargalló, Núria|||0000-0001-6284-5402
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Belbin, Olivia|||0000-0002-6109-6371
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Giménez, Sandra|||0000-0001-8031-2319
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Hernandez, Aida S.
Background and Objectives Cerebral hemorrhages are an exclusion criterion and potential adverse effect of antiamyloid agents. It is, therefore, critical to characterize the natural history of cerebral microbleeds in populations genetically predisposed to Alzheimer disease (AD), such as Down syndrome (DS). We aimed to assess microbleed emergence in adults with DS across the AD spectrum, defining their topography and associations with clinical variables, cognitive outcomes, and fluid and neuroimaging biomarkers. Methods This cross-sectional study included participants aged 18 years or older from the Down-Alzheimer Barcelona Neuroimaging Initiative and Sant Pau Initiative on Neurodegeneration with T1-weighted and susceptibility-weighted images. Participants underwent comprehensive assessments, including apolipoprotein E (APOE) genotyping; fluid and plasma determinations of beta-amyloid, tau, and neurofilament light; cognitive outcomes (Cambridge Cognitive Examination and modified Cued Recall Test); and vascular risk factors (hypertension, diabetes mellitus, and dyslipidemia). We manually segmented microbleeds and characterized their topography. Associations between microbleed severity and AD biomarkers were explored using between-group comparisons (none vs 1 vs 2+) and multivariate linear models. Results We included 276 individuals with DS and 158 healthy euploid controls (mean age = 47.8 years, 50.92% female). Individuals with DS were more likely to have microbleeds than controls (20% vs 8.9%, p < 0.001), with more severe presentation (12% with 2+ vs 1.9%). Microbleeds increased with age (12% 20-30 years vs 60% > 60 years) and AD clinical stage (12.42% asymptomatic, 27.9% prodromal, 35.09% dementia) were more common in APOEe4 carriers (26% vs 18.3% noncarriers, p = 0.008), but not associated with vascular risk factors (p > 0.05). Microbleeds were predominantly posterior (cerebellum 33.66%; occipital 14.85%; temporal 21.29%) in participants with DS. Associations with microbleed severity were found for neuroimaging and fluid AD biomarkers, but only hippocampal volumes (standardized β = -0.18 [-0.31, -0.06], p < 0.005) and CSF p-tau-181 concentrations (β = 0.26 [0.12, 0.41], p < 0.005) survived regression controlling for age and disease stage, respectively. Microbleeds had limited effect on cognitive outcomes. Discussion In participants with DS, microbleeds present with a posterior, lobar predominance, are associated with disease severity, but do not affect cognitive performance. These results suggest an interplay between AD pathology and vascular lesions, implicating microbleeds as a risk factor limiting the use of antiamyloid agents in this population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients

  • Hok-A-Hin, Yanaika S.|||0000-0001-9713-116X
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Barkhof, Frederik|||0000-0003-3543-3706
  • del Campo, Marta
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Vermunt, Lisa
  • Oosthoek, Marlies
  • Vijverberg, Everard G.B.
  • Blujdea, Elena R.
  • Veld, Sjors G.J.G.In't
  • Pucheu Avilés, Martín
  • Zsadanyi, Sara E.|||0000-0002-2033-5989
  • Visser, Allerdien
  • Schut, Martijn C.
Background: Amyloid-related imaging abnormalities (ARIA) are a common and potentially dangerous side effect in anti-amyloid therapies, creating a need for tools to assess ARIA risk. Several patient factors have been linked to ARIA; namely the presence of microbleeds (MBL), APOE E4 carriership (APOE4), and extremely low CSF Aβ42 concentrations (A). We hypothesize that studying the CSF proteome of Alzheimer's disease (AD) dementia patients from a high-risk group (MBLAPOE4A) can inform on the biological underpinnings of ARIA risk and aid the progress of ARIA risk biomarkers. Methods: We utilized CSF proteomic data of AD (n = 156) and cognitively unimpaired individuals (CU n = 100) of the Amsterdam Dementia Cohort. The proteome of the defined high-risk (n = 13) was compared to low-risk AD group (n = 23), using age and sex corrected linear regressions followed by gene ontology analysis. For biomarker prioritization, we selected proteins that were abnormal in the high-risk group versus low-risk and CU patients. The biomarkers were validated in an independent cohort (high risk n = 14, low risk n = 9) analyzed using customized multiplex panels. Lastly, we assessed biomarker lead co-expression. Results: Ninety-four proteins differentiated in the high-risk group compared to low-risk (p < 0.05), none surviving FDR correction. These proteins were enriched for synapse-related proteins and axonogenesis. CHIT1 (vs. low-risk AD: FC = 1.0, p = 0.014, vs. CU: FC = 2.4, p < 0.001) and DDAH1 (vs. low-risk AD: FC=-0.31, p = 0.046, vs. CU: FC = 0.5, p < 0.001) were prioritized as biomarker. DDAH1 protein changes replicated in an independent cohort (FC=-0.37, p = 0.010), and CHIT1 replicated on a trend level (FC = 0.70, p = 0.104). DDAH1 levels had the highest co-expression with synaptic process, energy utilization and RNA-binding cell signaling related proteins (R > 0.8). Conclusions: The findings suggest that in the high risk group, there is a lack of upregulation in synapse and axonogenesis related proteins. High CSF CHIT1 and less increased CSF DDAH1 levels within AD relate to ARIA risk. From the literature, the link to ARIA risk for CHIT1 could be its contribution to innate immunity or vascular amyloid deposition, and for DDAH1 to blood-brain barrier integrity. Biomarker assays are available to assess the potential of CHIT1 and DDAH1 in trials and treatment studies in the clinical setting.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Applied Artificial Intelligence in Materials Science and Material Design

  • Chávez Ángel, Emigdio|||0000-0002-9783-0806
  • Eriksen, Martin|||0000-0003-0601-0990
  • Castro-Alvarez, Alejandro|||0000-0001-8360-8027
  • Garcia, José H.|||0000-0002-5752-4759
  • Botifoll, Marc|||0000-0002-4876-6393
  • Avalos-Ovando, Oscar
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Mugarza, Aitor|||0000-0002-2698-885X
Materials science has traditionally relied on a combination of experimental techniques and theoretical modeling to discover and develop new materials with desired properties. However, these processes can be time-consuming, resource-intensive, and often limited by the complexity of material systems. The advent of artificial intelligence (AI), particularly machine learning, has revolutionized materials science by offering powerful tools to accelerate the discovery, design, and characterization of novel materials. AI not only enhances the predictive modeling of material properties but also streamlines data analysis in techniques like X-Ray diffraction, Raman spectroscopy, scanning probe microscopy, and electron microscopy. By leveraging large datasets, AI algorithms can identify patterns, reduce noise, and predict material behavior with unprecedented accuracy. In this review, recent advancements in AI applications across various domains of materials science, including spectroscopy, synchrotron studies, scanning probe and electron microscopies, metamaterials, atomistic modeling, molecular design, and drug discovery, are highlighted. It is discussed how AI-driven methods are reshaping the field, making material discovery more efficient, and paving the way for breakthroughs in material design and real-time experimental analysis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old

  • Ceriello, Chiara
  • Torres Bonafonte, Olga H.|||0000-0002-0305-8211
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Vera-Campuzano, Elena
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Álvarez-Sánchez, Esther|||0009-0002-8760-2153
  • Lorente, Oriol
  • Carreras, Mireia
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Belbin, Olivia|||0000-0002-6109-6371
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
Background and Objectives: Alzheimer disease (AD) is increasingly viewed as a clinical-biological continuum, but the utility of biomarkers in individuals aged ≥80 years, the so-called “very old,” remains uncertain, because of concerns about its clinical usefulness. This study aimed to determine the clinical impact and prognostic value of AD biomarkers in very old individuals. Methods: We performed a retrospective longitudinal cohort study within the Sant Pau Initiative on Neurodegeneration (SPIN, Barcelona, Spain), a memory clinic–based research cohort. Patients were referred from primary care physicians or community neurologists for evaluation within a public universal health care catchment area. We included SPIN participants evaluated between October 2013 and May 2024 who were aged ≥80 years and had mild cognitive impairment (MCI) at the baseline visit. Participants underwent standardized clinical and neuropsychological assessments and had CSF and plasma biomarker measurements available. AD biology was defined by the CSF phosphorylated tau at threonine 181/amyloid-β 42 ratio. Plasma phosphorylated tau at threonine 217 (p-Tau217) was evaluated for (1) diagnostic accuracy for AD biology and (2) prognostic associations with longitudinal cognitive change (Mini-Mental State Examination [MMSE]) and progression to dementia. Analyses used linear mixed-effects models for MMSE trajectories and Cox regression for dementia conversion. Results: A total of 167 participants were included (mean age 82.3 years, 59% women) with a mean follow-up of 35.8 months; the ones with AD biology (n = 116, 69%) had worse baseline cognitive performance, particularly in memory, compared with those without (Cohen d = 0.34, p = 0.03). Plasma p-Tau217 showed excellent diagnostic accuracy for detecting AD biology (0.93, 95% CI 0.88–0.98; cutoff 0.19 pg/mL; sensitivity 94.5%; specificity 84%). Over time, participants with AD biology declined faster on the MMSE than those without (−0.47 vs −0.18 points per year; p < 0.01). Cox models showed an increased risk of progression to a dementia stage among individuals with higher plasma p-Tau217 concentrations (hazard ratio 1.49, 95% CI 1.05–2.13, p = 0.026). Discussion: In very old individuals with MCI, AD biology (CSF) and plasma p-Tau217 identify individuals at higher risk of faster cognitive decline and progression to dementia. Limitations of this study include the single-center design and the modest sample size.
Repisalud
Publication Artículo científico (JournalArticle)

Conflicts of interest in research on electronic cigarettes

  • Martínez, Cristina
  • Fu, Marcela
  • Galan, Iñaki
  • Pérez-Ríos, Mónica
  • Martínez-Sánchez, Jose M
  • López, Maria J
  • Sureda, Xisca
  • Montes, Agustín
  • Fernández, Esteve
INTRODUCTION: The tobacco control community has raised some concerns about whether studies on electronic cigarettes (e-cigarettes) published in scientific journals hide conflicts of interest (COI) and whether such reports are biased. This study assessed potential COI in the e-cigarette scientific literature. METHODS: Cross-sectional study was conducted on e-cigarette publications indexed in PubMed up to August 2014. We extracted information about the authors (affiliations, location, etc.), publication characteristics (type, topic, subject, etc.), results and conclusions, presence of a COI statement, and funding by and/or financial ties to pharmaceutical, tobacco, and/or e-cigarette companies. An algorithm to determine the COI disclosure status was created based on the information in the publication. Prevalence ratios (PRs) and confidence intervals (CIs) were calculated to identify associations with COI disclosure, controlling for several independent variables. RESULTS: Of the 404 publications included in the analysis, 37.1% (n=150) had no COI disclosure statement, 38.6% declared no COI, 13.4% declared potential COI with pharmaceutical companies, 3.0% with tobacco companies, and 10.6% with e-cigarette companies. The conclusions in publications with COI, which were mainly tied to pharmaceutical companies, were more likely to be favourable to e-cigarette use (PR=2.23; 95% CI: 1.43-3.46). Publications that supported the use of e-cigarettes for both harm reduction (PR=1.81; 95%CI: 1.14-2.89) and smoking cessation (PR=2.02; 95% CI: 1.26-3.23) were more likely to have conclusions that were favourable to e-cigarettes. CONCLUSIONS: One-third of the publications reporting studies on e-cigarettes did not have a COI disclosure statement, and this proportion was even higher in news articles, editorials and other types of publications. Papers with conclusions that were favourable to e-cigarette use were more likely to have COI. Journal editors and reviewers should consider evaluating publications, including funding sources, to determine whether the results and conclusions may be biased.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

La Ferradura d&apos, Ulldecona (Catalunya) revisitada. Un punt de control territorial de la primera edat del ferro al nord-est de la península Ibèrica., La Ferradura (Ulldecona, Catalonia) Revisited: A Territorial Control Point of the Early Iron Age in the North-East of the Iberian Peninsula

  • Garcia i Rubert, David
  • Mateu, Marta
  • Rodés, Margarita
  • Roca, Mercé
  • Font Valentín, Laia
  • Saorin, Carme
  • Freixas Roig, Tania
  • Carbonell, Sonia
  • Serrano, Ana
[EN] The Ferradura site in Ulldecona, Catalonia, was first identified and excavated in 1972 under the direction of J. Maluquer de Motes. This initial campaign uncovered a series of eleven structures arranged linearly, spanning a total area of approximately 400 square meters. The settlement occupies a modest elevation relative to its immediate surroundings and exhibits a strategic relationship with local and regional communication routes. Culturally, it represents a single-phase occupation dated to the Early Iron Age (800¿550 BCE). In 2009, the GRAP (Research Group in Protohistoric Archaeology, University of Barcelona) resumed excavations at the site. Their objectives were to reassess the findings from the 1972 campaign and to deepen the study of the site¿s archaeological record. This article presents the first comprehensive synthesis of the work undertaken to date and its results, encompassing both the portable and immovable archaeological remains and offering a functional interpretation of the site within its broader territorial context., Volem agrair a les institucions que financen i donen suport a les intervencions i als posteriors treballs de recerca i de difusió, com són l Ajuntament d Ulldecona i el Servei d Arqueologia i Paleontologia de la Generalitat de Catalunya (a: Indígenes i fenicis. Tot calibrant l impacte de la presència fenícia a les terres del Sénia , Ajuts per a projectes quadriennals de recerca en matèria d arqueologia i paleontologia, Generalitat de Catalunya, referència 7495D/749000104/4431/ 0000. b: Ajuts per a municipis i comarques per a inversions en la gestió del patrimoni arqueològic i paleontològic, 2022 i 2023). I, especialment, als equips humans que campanya rere campanya participen a les excavacions ja que sense ells tot això tampoc no seria possible. Marta Mateu compta amb el suport del programa postdoctoral Beatriu de Pinós del Departament de Recerca i Universitats de la Generalitat de Catalunya (2021BP00103). Carme Saorin és beneficiària d un contracte predoctoral FPI (PGC2018-099579-B-I00) finançat per MICIU/ AEI/10.13039/501100011033 i FSE Invierte en tu futuro .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Profile of plasma microRNAs as a potential biomarker of Wilson&apos, s disease

  • Sánchez-Monteagudo, Ana
  • Ripollés, Edna
  • Murillo, Oihana
  • Domènech, Sofia
  • Álvarez-Sauco, María
  • Girona, Eva
  • Sastre-Bataller, Isabel
  • Bono, Ariadna
  • García-Villarreal, Luis
  • Tugores, Antonio
  • García-García, Francisco
  • González-Aseguinolaza, Gloria
  • Berenguer, Marina
  • Espinós-Armero, Carmen
[EN] Background: Wilson's disease (WD) is a rare condition resulting from autosomal recessive mutations in ATP7B, a copper transporter, manifesting with hepatic, neurological, and psychiatric symptoms. Timely diagnosis and appropriate treatment yield a positive prognosis, while delayed identification and/or insufficient therapy lead to a poor outcome. Our aim was to establish a prognostic method for WD by characterising biomarkers based on circulating microRNAs. Methods: We conducted investigations across three cohorts: discovery, validation (comprising unrelated patients), and follow-up (revisiting the discovery cohort 3 years later). All groups were compared to age- and gender-matched controls. Plasma microRNAs were analysed via RNA sequencing in the discovery cohort and subsequently validated using quantitative PCR in all three cohorts. To assess disease progression, we examined the microRNA profile in Atp7b-/- mice, analysing serum samples from 6 to 44 weeks of age and liver samples at three time points: 20, 30, and 40 weeks of age. Results: In patients, elevated levels of the signature microRNAs (miR-122-5p, miR-192-5p, and miR-885-5p) correlated with serum activities of aspartate transaminase, alanine aminotransferase and gamma-glutamyl transferase. In Atp7b-/- mice, levels of miR-122-5p and miR-192-5p (miR-885-5p lacking a murine orthologue) increased from 12 weeks of age in serum, while exhibiting fluctuations in the liver, possibly attributable to hepatocyte regenerative capacity post-injury and the release of hepatic microRNAs into the bloodstream. Conclusions: The upregulation of the signature miR-122-5p, miR-192-5p, and miR-885-5p in patients and their correlation with liver disease progression in WD mice support their potential as biomarkers of WD., are in debt with the patients and their families for agreeing to participate in this study. The authors also thank Aida Regi-Cosculluela and Faustino Gimenez-Felices, Spanish association of patients with Wilson disease (AEFE Wilson), always willing to bring science closer to patients and their families. This study has been funded by the Fundacio Per Amor a l'Art (FPAA); by the Instituto de Salud Carlos III (ISCIII) through the projects PI18/00147 and PI21/00103 to CE, PI21/00313 to OM, and INT20/00061 to MB, and co-funded by the European Union; by MCIN/AEI/https://doi.org/10.13039/501100011033 and by "ERDF A way of, making Europe" through the project PID2021-124455OB-I00 to GGA; and by the Centro de Investigacion Biomedica en Red (CIBER) through the project CB06/04/0065 to MB. Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF (OP ERDF of Comunitat Valenciana 2014-2020). ER has a PhD fellowship from the Generalitat Valenciana [CIACIF/2021/252].
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adults

  • Mallah, Narmeen
  • Pardo Seco, Jacobo José
  • Rodríguez-Tenreiro Sánchez, Carmen
  • Giné Vázquez, Iago
  • Mirás Carballal, Susana
  • Piñeiro Sotelo, Marta
  • Cribeiro González, Martín
  • Conde Pájaro, Mónica
  • González Pérez, Juan Manuel
  • Razzini, Josefina Lorena
  • Rivero Calle, Irene
  • Dacosta Urbieta, Ana Isabel
  • Harris, Rebecca C.
  • Loiacono, Matthew M.
  • van Aalst, Robertus
  • Farre, Joan Manel
  • Dufournet, Marine
  • Johansen, Niklas Dyrby
  • Modin, Daniel
  • Biering-Sørensen, Tor
  • Durán Parrondo, Carmen
  • Martinón Torres, Federico
Introduction: Optimizing influenza vaccination in older adults is a public health priority. While high-dose inactivated influenza vaccines (HD-IIV) have shown superior immunogenicity and efficacy over standard-dose vaccines (SD-IIV), there is a shortage of large-scale, individually randomized data evaluating real-world effectiveness against severe outcomes—especially within publicly funded health systems. Methods: GALFLU is a pragmatic, individually randomized, open-label clinical trial comparing HD-IIV and SD-IIV in adults aged 65–79 years in Galicia, Spain, during the 2023–2024 and 2024–2025 influenza seasons. The trial embedded individual randomization into the regional vaccination program and exploited digital health registries for comprehensive, low-burden data collection under real-world conditions. The primary outcome is relative vaccine effectiveness (rVE) against a composite of influenza- or pneumonia-related hospitalizations. Secondary and exploratory outcomes include rVE against cardio-respiratory hospitalization, laboratory-confirmed influenza hospitalization, all-cause hospitalization, mortality, and healthcare utilization. The GALFLU protocol was approved by the Comité de ética de la investigación con medicamentos de Galicia (CEIm-G, code 2023/374). Participation was fully voluntary. Results: GALFLU demonstrated the feasibility of large-scale, pragmatic randomized controlled trials within routine clinical practice. Findings from GALFLU will be disseminated in peer-reviewed scientific journals and scientific meetings and shared with relevant authorities. Conclusions: GALFLU provides a reproducible blueprint for future pragmatic evaluations embedded in routine public health settings.
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Pseudo-nitzschia species on the Catalan coast: characterization and contribution to the current knowledge of the distribution of this genus in the Mediterranean Sea

  • Quijano-Scheggia, Sonia
  • Garcés, Esther
  • Andree, Karl
  • de la Iglesia, Pablo
  • Diogène, Jorge
  • Fortuño, Jose-Manuel
  • Camp, Jordi
Proliferations of the genus Pseudo-nitzschia recur along the Catalan coast (NW Mediterranean) throughout the year. The establishment of 58 clonal cultures facilitated morphological studies with scanning electron microscopy (SEM) and ITS 5.8S rDNA sequence characterization. Moreover, strains of each species were examined with respect to sexual compatibility and toxicity. The results of the morphological and phylogenetic studies confirmed nine species of the genus Pseudo-nitzschia: P. brasiliana, P. calliantha, P. delicatissima clade A/del 2, P. arenysensis, P. fraudulenta, P. galaxiae, P. linea, P. multistriata and P. pungens clade I. Moreover, two Pseudo-nitzschia species, P. caciantha and P. cf mannii, could only be identified following SEM analysis of their morphology. None of the cultured strains of Pseudo-nitzschia analyzed produced domoic acid in amounts above the limit of detection. The current distributions of the Pseudo-nitzschia species in the Mediterranean Sea were plotted on maps, which led to the following observations: i) diversity within this genus is much greater than previously considered, ii) some species have a broad distribution (e.g. P. calliantha), iii) whereas the distribution of others is narrowly restricted (e.g. P. pungens clade I). Moreover, this study reports the first detection of P. linea in the Mediterranean Sea and is the first description of P. galaxiae and P. cf mannii along the Catalan coast. Morphological studies coupled with molecular biological characterization, mating tests and biogeographic distribution analyses provide a critical theoretical basis for testing and/or implementing the current phylogenetic framework in the genus Pseudo-nitzschia., This study was funded by ACA (Generalitat de Catalunya), CSIC, the EC-funded Research Project SEED, GOCE-CT- 2005-003875 and the Programa de seguiment de la qualitat de les aigües, mol.luscs i fitoplancton tòxic a les zones de producció de marisc del litoral català de la DGPIAM and the Xarxa de Referència de Recerca i Desenvolupament en Aqüicultura. IRTA acknowledges financial support from the Instituto Nacional de Investigación Agraria (INIA) through the project RTA2006-00103-00-00. S. Quijano-Scheggia’s work was supported by a PROMEP grant, Universidad de Colima, México. E. Garcés’s work was supported by a Ramon y Cajal contract from the Spanish Ministry of Science and Education., info:eu-repo/semantics/publishedVersion
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Geometrical modelling of corneal structure in non-pathological initial conditions. A comparative study, Modelado geométrico de la estructura corneal en condiciones iniciales no patológicas. Un estudio comparativo

  • Gómez, Carmelo
  • Piñero, David P.
  • Velázquez, José S.
  • Sáez-Gutiérrez, Francisco L.
  • Alió, Jorge L.
  • Cavas Martínez, Francisco
  • Piñero, David P.|||/items/02d2ffcc-a108-4e8d-ad21-df3b3fc92a22
Modelling and numerical simulation have involved a great advance in clinical practice for the prediction of the structural behaviour of soft tissues in certain healthy or pathological scenarios. One of the main features of these simulations is that they can define the geometric parameters of the structure in its initial boundary conditions. In the case of the cornea, there are discrepancies with respect to the initial conditions that depend on whether if it is considered its physiological geometry measured in vivo, or otherwise its geometry in its stress-free state. The choice of one or the other could lead to errors in the simulation model due to the non-linearity of these tissues. In this study, two methodologies were evaluated, the displacement method and the prestress method, to obtain the geometry of non-pathological cornea in its free-of-stress state. Both methodologies allow obtaining the physiological geometry measured in-vivo of the healthy cornea, however, the method of displacements presents a computational architecture that makes it more efficient in numerical simulation, when compared to the pre-stress method.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Multimodal classification of keratoconus progression using corneal surface geometry and refractive data: the role of peripheral regions and missing-data patterns

  • Cano Espinosa, Carlos
  • González, Jose
  • Gómez, Carmelo
  • Bolarín, José Miguel
  • Alio del Barrio, Jorge
  • Cavas Martínez, Francisco
  • Cano Espinosa, Carlos|||/items/d608122c-3abd-44e1-b3be-b152b22b6c71
Early detection of ocular pathologies is crucial for improving treatment outcomes and preventing severe vision impairment. Keratoconus is a progressive corneal disorder characterized by thinning and irregular deformation of the cornea, which leads to visual distortion and may ultimately require corneal transplantation. Accurate detection and staging of keratoconus progression are therefore essential for effective clinical management. This study presents a multimodal framework for classifying keratoconus stages by integrating raw anterior and posterior corneal point cloud data acquired with Sirius topographer together with clinically derived refractive parameters. The proposed approach combines surface-based deep learning with traditional machine learning models for tabular clinical data, enabling joint exploitation of structural and optical information. Beyond classification performance, the study investigates the diagnostic role of peripheral corneal regions and acquisition-related missing-data patterns through dedicated analyses. The results indicate that peripheral measurements and structured missing-data distributions contain diagnostically relevant information that complements central corneal features. Overall, the proposed multimodal strategy improves keratoconus classification performance while providing new insights into the spatial and acquisition-related cues that contribute to disease staging, highlighting the potential of data-driven approaches to support clinical decision-making in keratoconus management.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Bidirectional Photoswitching of a Tailored Azobenzene with Red and Far-Red Light Involving Triplet Sensitization in an Aqueous System

  • Miroshnichenko, Mila
  • Hölzel, Helen
  • Orentas, Edvinas
  • Kazlauskas, Karolis
  • Ferreira, Pedro
  • Dumoulin, Fabienne
  • Alcaide, Carles
  • Solà, Miquel
  • Bresolí-Obach, Roger
  • Nonell, Santi
  • Bharmoria, Pankaj
  • Moth-Poulsen, Kasper
Shifting action spectrum of azobenzene-based photopharmaceuticals toward bio-optical window is highly desired, since red/far-red light offers improved tissue penetration and reduced cellular toxicity. While unidirectional photoswitching (trans-to-cis and cis-to-trans) of azobenzenes (AZO) with red/far-red light is known in separate systems, achieving bidirectional photoswitching in a single system faces issues of spectral overlaps. Here, bidirectional photoswitching of a tailored azobenzene is achieved in a single bio-relevant solution with red and far-red light excitation. A new azobenzene molecule (AZO-N) bearing four ortho-methoxy, and one para-N donor lipophile is synthesized. The AZO-N exhibits separate n-π* absorption bands and triplet energies for trans and cis isomers. As a result, trans-to-cis photoswitching is observed upon 625 nm excitation at the tail of the red-shifted n-π*absorption band via direct absorption, whereas cis-to-trans photoswitching is enabled upon 730 nm excitation through triplet sensitization. Further, triplet sensitization of AZO-based molecules could lead to singlet oxygen generation—experiments in the presence of serum albumin and glutathione (biological oxidative stress addressors), suggest no effect of singlet oxygen on the triplet-sensitization of cis-AZO-N, and non-significant change in the fingerprint all-α secondary structure of serum albumin. This advance presents modular design principles to develop practically functional azo-based photopharmaceuticals., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias

  • Martínez-Rubio, Dolores
  • Hinarejos, Isabel
  • Sancho, Paula
  • Gorría-Redondo, Nerea
  • Bernado-Fonz, Raquel
  • Tello, Cristina
  • Marco-Marín, Clara
  • Martí-Carrera, Itxaso
  • Martínez-González, María Jesús
  • García-Ribes, Ainhoa
  • Baviera-Muñoz, Raquel
  • Sastre-Bataller, Isabel
  • Martínez-Torres, Irene
  • Duat-Rodriguez, Anna
  • Janeiro, Patricia
  • Moreno, Esther
  • Pías-Peleteiro, Leticia
  • Gordo, Mar
  • O'Callaghan Ruiz-Gómez, Ángeles
  • Muñoz, Esteban
  • Martí, Maria Josep
  • Sánchez-Monteagudo, Ana
  • Fuster, Candela
  • Andrés-Bordería, Amparo
  • Pons, Roser Maria
  • Jesús-Maestre, Silvia
  • Mir, Pablo
  • Lupo, Vincenzo
  • Pérez-Dueñas, Belén
  • Darling, Alejandra
  • Aguilera-Albesa, Sergio
  • Espinós, Carmen
26 páginas, 4 figuras, 3 tablas, Our clinical series comprises 124 patients with movement disorders (MDs) and/or ataxia with cerebellar atrophy (CA), many of them showing signs of neurodegeneration with brain iron accumulation (NBIA). Ten NBIA genes are accepted, although isolated cases compatible with abnormal brain iron deposits are known. The patients were evaluated using standardised clinical assessments of ataxia and MDs. First, NBIA genes were analysed by Sanger sequencing and 59 patients achieved a diagnosis, including the detection of the founder mutation PANK2 p.T528M in Romani people. Then, we used a custom panel MovDisord and/or exome sequencing; 29 cases were solved with a great genetic heterogeneity (34 different mutations in 23 genes). Three patients presented brain iron deposits with Fe-sensitive MRI sequences and mutations in FBXO7, GLB1, and KIF1A, suggesting an NBIA-like phenotype. Eleven patients showed very early-onset ataxia and CA with cortical hyperintensities caused by mutations in ITPR1, KIF1A, SPTBN2, PLA2G6, PMPCA, and PRDX3. The novel variants were investigated by structural modelling, luciferase analysis, transcript/minigenes studies, or immunofluorescence assays. Our findings expand the phenotypes and the genetics of MDs and ataxias with early-onset CA and cortical hyperintensities and highlight that the abnormal brain iron accumulation or early cerebellar gliosis may resembling an NBIA phenotype., This work was supported by the Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R + D+I Plan co-funded with European Regional Development Funds (ERDF) [Grants PI18/00147 and PI21/00103 to CE]; the Fundació La Marató TV3 [Grants 20143130 and 20143131 to BPD and CE]; and by the Generalitat Valenciana [Grant PROMETEO/2018/135 to CE]. Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF (OP ERDF of Comunitat Valenciana 2014–2020). PS had an FPU-PhD fellowship funded by the Spanish Ministry of Education, Culture and Sport [FPU15/00964]. IH has a PFIS-PhD fellowship [FI19/00072]. ASM has a contract funded by the Spanish Foundation Per Amor a l’Art (FPAA), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3

  • Martínez-Rubio, Dolores
  • Rodríguez-Prieto, Ángela
  • Sancho, Paula
  • Navarro-González, Carmen
  • Gorría-Redondo, Nerea
  • Miquel-Leal, Javier
  • Marco-Marín, Clara
  • Jenkins, Alison
  • Soriano-Navarro, Mario
  • Hernández, Alberto
  • Pérez-Dueñas, Belén
  • Fazzari, Pietro
  • Aguilera-Albesa, Sergio
  • Espinós, Carmen
17 páginas, 8 figuras, Peroxiredoxin 3 (PRDX3) encodes a mitochondrial antioxidant protein, which is essential for the control of reactive oxygen species homeostasis. So far, PRDX3 mutations are involved in mild-to-moderate progressive juvenile onset cerebellar ataxia. We aimed to unravel the molecular bases underlying the disease in an infant suffering from cerebellar ataxia that started at 19 months old and presented severe cerebellar atrophy and peripheral neuropathy early in the course of disease. By whole exome sequencing, we identified a novel homozygous mutation, PRDX3 p.D163E, which impaired the mitochondrial ROS defense system. In mouse primary cortical neurons, the exogenous expression of PRDX3 p.D163E was reduced and triggered alterations in neurite morphology and in mitochondria. Mitochondrial computational parameters showed that p.D163E led to serious mitochondrial alterations. In transfected HeLa cells expressing the mutation, mitochondria accumulation was detected by correlative light electron microscopy. Mitochondrial morphology showed severe changes, including extremely damaged outer and inner membranes with a notable cristae disorganization. Moreover, spherical structures compatible with lipid droplets were identified, which can be associated with a generalized response to stress and can be involved in the removal of unfolded proteins. In the patient's fibroblasts, PRDX3 expression was nearly absent. The biochemical analysis suggested that the mutation p.D163E would result in an unstable structure tending to form aggregates that trigger unfolded protein responses via mitochondria and endoplasmic reticulum. Altogether, our findings broaden the clinical spectrum of the recently described PRDX3-associated neurodegeneration and provide new insight into the pathological mechanisms underlying this new form of cerebellar ataxia., The Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R + D + I Plan cofunded with European Regional Development Funds (ERDF) (grants PI18/00147 and PI21/00103 to C.E.); the Spanish Ministry of Economy and Competitiveness (grant SAF2017-89020-R to P.F.); the Fundació La Marató TV3 (grants 20143130 and 20143131 to B.P.-D. and C.E.) and the Generalitat Valenciana (grant PROMETEO/2018/135 to C.E.). Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF (OP ERDF of Comunitat Valenciana 2014-2020). P.F. and A.R.-P. are supported by the Spanish Ministry of Science and Innovation (grants RyC-2014-16410 to P.F. and PRE2018-083562 to A.R.-P.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Machine learning in electron microscopy for advanced nanocharacterization: current developments, available tools and future outlook

  • Botifoll, Marc
  • Pinto, Iván
  • Arbiol, Jordi
In the last few years, electron microscopy has experienced a new methodological paradigm aimed to fix the bottlenecks and overcome the challenges of its analytical workflow. Machine learning and artificial intelligence are answering this call providing powerful resources towards automation, exploration, and development. In this review, we evaluate the state-of-the-art of machine learning applied to electron microscopy (and obliquely, to materials and nano-sciences). We start from the traditional imaging techniques to reach the newest higher-dimensionality ones, also covering the recent advances in spectroscopy and tomography. Additionally, the present review provides a practical guide for microscopists, and in general for material scientists, but not necessarily advanced machine learning practitioners, to straightforwardly apply the offered set of tools to their own research. To conclude, we explore the state-of-the-art of other disciplines with a broader experience in applying artificial intelligence methods to their research (e.g., high-energy physics, astronomy, Earth sciences, and even robotics, videogames, or marketing and finances), in order to narrow down the incoming future of electron microscopy, its challenges and outlook., The authors acknowledge funding from Generalitat de Catalunya 2017 SGR 327. ICN2 is supported by the Severo Ochoa programme from the Spanish Ministry of Economy (MINECO) (grant no. SEV-2017-0706) and is funded by the CERCA Programme/Generalitat de Catalunya. The authors thank support from the project NANOGEN (PID2020-116093RB-C43), funded by MCIN/AEI/10.13039/501100011033/and by “ERDF A way of making Europe”, by the “European Union”. M. B. acknowledges funding from SUR Generalitat de Catalunya and the EU Social Fund; project ref. 2020 FI 00103. This study was supported by MCIN with the funding form European Union NextGenerationEU (PRTR-C17-I1) and Generalitat de Catalunya. This study was supported by EU HORIZON INFRA TECH 2022 project IMPRESS (Ref.: 101094299).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

CDH1 Regula la mielinización durante el desarrollo del sistema nervioso central

  • Gomila Huguet, Silvia
Trabajo presentado para lograr el título de Doctor por la Universidad de Salamanca, Programa de Doctorado en Biología Funcional y Genómica, APC/C-Cdh1 desempeña una función esencial en el desarrollo del sistema nervioso, donde coordina la salida de los progenitores neurales del ciclo celular y el inicio de la neurogénesis y, con ello, el tamaño del encéfalo y organización de la corteza cerebral. Recientemente, hemos identificado una nueva mutación de Cdh1 (Asp187Gly) que causa pérdida de actividad de APC/C-Cdh1 y provoca microcefalia, retraso psicomotor y epilepsia en humanos. Estos trastornos están asociados tanto con alteraciones en la neurogénesis, como en la oligodendrogénesis y mielinización. Es más, un examen preliminar imagenológico del encéfalo del paciente que portaba la mutación de Cdh1 mostró una disminución de la sustancia blanca y disgénesis del cuerpo calloso. Por todo ello, creemos que APC/C-Cdh1 podría desempeñar un papel clave en la oligodendrogénesis y la mielinización durante el desarrollo postnatal., Este trabajo ha sido financiado con proyectos de investigación concedidos por el Instituto de Salud Carlos III (PI18/00103, PI21/00727, RD21/0006/0005 co-financiado por la Unión Europea) y la Junta de Castilla y León (CSI151P20; Escalera de Excelencia CLU 2017-03 co-financiada por la Unión Europea). Silvia Gomila obtuvo un contrato predoctoral financiado por el Instituto de Investigación Biomédica de Salamanca (IBSAL).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Control nucleocitoplasmático del complejo Calpaína- 2/Calpastatina durante la tolerancia isquémica neuronal

  • Hermosín Montes, J. M.
Trabajo presentado para lograr el título de Doctor por la Universidad de Salamanca, Departamento de Bioquímica y Biología Molecular, Programa de Doctorado en Biología Funcional y Genómica, La homeostasis celular se mantiene gracias a los sistemas de control de la síntesis y degradación de proteínas, como son el sistema ubiquitina-proteasoma, el de autofagia-lisosomal y las proteasas. En este sentido, las proteasas no lisosomales, conocidas como calpaínas, constituyen un sistema complejo de modulación de la función proteica durante el desarrollo de numerosas patologías, incluidas las neurológicas, como es la isquemia. Junto a la excitotoxicidad, la entrada intracelular de calcio, el control en la estabilidad proteica y la generación de especies reactivas de oxígeno, la activación de las calpaínas es un factor clave implicado en la muerte neuronal inducida por la cascada isquémica. Por tanto, las estrategias neuroprotectoras encaminadas a la interrupción de los mecanismos que desencadenan este fenómeno y, en concreto, el sistema de las calpaínas puede tener una importante relevancia en la resistencia frente al daño isquémico. Nosotros pensamos que el precondicionamiento isquémico, una conocida herramienta de neuroprotección endógena, podría estar implicado en la regulación del sistema de las calpaínas y por lo tanto en la respuesta de tolerancia isquémica neuronal. Con estos antecedentes, y puesto de manifiesto la importancia que posee el control de la estabilización de las proteínas durante la isquemia, en la presente Tesis Doctoral nos hemos propuesto identificar la función de las calpaínas durante la tolerancia neuronal en respuesta al daño isquémico., Este trabajo ha sido financiado con proyectos de investigación concedidos por el Instituto de Salud Carlos III (CP0014/00010, PI18/00103, PI21/00727 y RD21/0006/0005, co-financiados por la Unión Europea) y la Junta de Castilla y León (CSI151P20; Escalera de Excelencia CLU 2017-03 cofinanciada por la Unión Europea FEDER/FSE+ and NextGenerationEU). Jesús Hermosín obtuvo un contrato predoctoral de personal investigador de la Junta de Castilla y León (EDU/556/2019).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Percepciones del envase neutro del tabaco entre fumadores y no fumadores en Andalucía (España)

  • Lacave-García, B.
  • Rey-Pino, J.M.
  • Gallopel-Morvan, K.
  • Moodie, C.
  • Fernández, E.
  • Nerín, I.
Objectives: Each year tobacco is responsible for 650, 000 deaths in Europe and 55, 000 in Spain. With tobacco advertising and promotion banned in Spain and most of Europe, the last bastion of marketing is the packaging. Plain tobacco packaging —which involves packs having a standardised appearance— has been proposed to counter this. The objective of this study is to research perceptions arising from the plain packaging of tobacco products. Methods: We employed a qualitative research methodology -focus groups- with smokers and non-smokers in in two medium-sized Andalusian towns (Spain). Results: Results show the importance of plain cigarette packaging as a form of promotion, particularly among women and young people, how pack colour influences product perceptions, and how removing full branding increases the salience of the warnings. Conclusions: Plain packaging, combined with pictorial health warnings, may reduce the capacity of packaging to be distinctive and a badge product. Altering pack design in such a way would make it more difficult for tobacco companies to create a favourable image of their brands and may help to reinforce the ability of the population to protect themselves from the dangers of smoking.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Length variation in the mouse mitochondrial tRNAArg DHU loop size promotes oxidative phosphorylation functional differences

  • Moreno-Loshuertos, Raquel
  • Pérez-Martos, Acisclo
  • Fernández-Silva, Patricio
  • Enríquez, José Antonio
The efficiency of the cellular oxidative phosphorylation system was recently shown to be modulated by common mitochondrial tRNA(A) (rg) haplotypes. The molecular mechanism by which some mt-Tr haplotypes induce these functional differences remains undetermined. Common polymorphisms in mouse mt-Tr genes affect the size of the dihydrouridine loop in the mature tRNA, producing loops of between five and seven nucleotides, the largest being a rare variant among mammals. Here, we analyzed a new mt-Tr variant identified in C3H mice, and found that it is mitochondrial tRNA loop size, but not the specific sequence, that is responsible for the observed differences in cellular respiration. We further found that the sensitivity of mitochondrial protein synthesis to specific inhibitors is dependent on the mt-Tr gene haplotype, and confirmed that the differences in oxidative phosphorylation performance are masked by a reactive oxygen species-induced compensatory increase in mitochondrial biogenesis.
Repositorio Digital UPCT
Publication Artículo científico (JournalArticle)

Geometrical modelling of corneal structure in non-pathological initial conditions. A comparative study, Modelado geométrico de la estructura corneal en condiciones iniciales no patológicas. Un estudio comparativo

  • Gómez García, Carmelo
  • Piñero Llorens, David Pablo
  • Velázquez Blázquez, José Sebastián
  • Sáez Gutiérrez, Francisco Luis
  • Alió Sanz, Jorge Luciano
  • Cavas Martínez, Francisco
Modelling and numerical simulation have involved a great advance in clinical practice for the prediction of the structural behaviour of soft tissues in certain healthy or pathological scenarios. One of the main features of these simulations is that they can define the geometric parameters of the structure in its initial boundary conditions. In the case of the cornea, there are discrepancies with respect to the initial conditions that depend on whether if it is considered its physiological geometry measured in vivo, or otherwise its geometry in its stress-free state. The choice of one or the other could lead to errors in the simulation model due to the non-linearity of these tissues. In this study, two methodologies were evaluated, the displacement method and the prestress method, to obtain the geometry of non-pathological cornea in its free-of-stress state. Both methodologies allow obtaining the physiological geometry measured in-vivo of the healthy cornea, however, the method of displacements presents a computational architecture that makes it more efficient in numerical simulation, when compared to the pre-stress method. | El modelado y la simulación numérica han supuesto un gran avance en la práctica clínica para la predicción del comportamiento estructural de los tejidos blandos en determinados escenarios sanos o patológicos. Una de las principales características de estas simulaciones es que pueden definir los parámetros geométricos de la estructura en sus condiciones de contorno iniciales. En el caso de la córnea, hay discrepancias con respecto a las condiciones iniciales que dependen de si se considera su geometría fisiológica medida in vivo, o de lo contrario su geometría en su estado libre de estrés. La elección de uno u otro podría conducir a errores en el modelo de simulación debido a la no linealidad de estos tejidos. En este estudio se evaluaron dos metodologías, el método de desplazamiento y el método de pretensado, para obtener la geometría de la córnea no patológica en su estado libre de estrés. Ambas metodologías permiten obtener la geometría fisiológica medida in vivo de la córnea sana, sin embargo, el método de desplazamientos presenta una arquitectura computacional que la hace más eficiente en la simulación numérica, en comparación con el método de pretensado, This publication was carried out within the framework of the project “Desarrollo y validación de un nuevo concepto de caracterización biomecánica-morfofuncional de la córnea” reference number DTS2021/00103. This Project has been funded by Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union.
O2, repositorio institucional de la UOC
Publication Artículo científico (JournalArticle)

The Tobacco Control Scale as a research tool to measure country-level tobacco control policy implementation

  • Feliu, Ariadna
  • Fernández, Esteve
  • Baena, Antoni
  • Joossens, Luk
  • Peruga, Armando
  • Fu, Marcela
  • Martinez, Cristina
Introduction. The Tobacco Control Scale (TCS) was designed for advocacy purposes but has also been used as a research tool. In the present study, we characterized TCS use, its limitations and strengths, and critically assessed its use as a research instrument. Methods. We conducted an extensive search of the biomedical databases PubMed and Web of Science for the keyword ‘tobacco control scale’ in all fields. The search was limited to studies published in the period March 2006 to December 2019. Out of 69 hits, 32 studies met the inclusion criteria. Two reviewers independently extracted information from each publication regarding their general characteristics, publication and research aspects, and the characteristics of the use of the TCS. Results. We found that researchers have used the TCS as a tool to monitor tobacco control policies mainly in cross-sectional observational studies with ecological and multilevel designs directed to advocacy and the promotion of further research. Different outcomes, such as smoking prevalence and quit ratios, have been associated with tobacco control policy scores. The main reported limitations of the TCS were a low variance across countries and a failure to express enforcement and to incorporate the most recent legislation. Conclusions. The TCS has been commonly used to assess differences in outcomes according to tobacco control policies. However, there are still areas for improvement in its use in research regarding the lack of comparability of TCS scores across time. The lessons that have been learned should be used to adapt and expand the TCS overseas.
O2, repositorio institucional de la UOC
Publication Artículo científico (JournalArticle)

Acceptability and participation predictors for a pragmatic randomized controlled trial to test a smoking cessation intervention after discharge from mental health wards

  • Martínez, Cristina
  • Feliu, Ariadna
  • Torres, Núria
  • Nieva, Gemma
  • Pinet, Cristina
  • Raich, Antònia
  • Mondon, Sílvia
  • Barrio, Pablo
  • Andreu, Magalí
  • Hernández-Ribas, Rosa
  • Vicens, Jordi
  • Costa, Sílvia
  • Suelves, Josep M
  • Vilaplana, Jordi
  • Enríquez, Marta
  • Alaustre, Laura
  • Vilalta, Eva
  • Subirà, Susana
  • Bruguera Cortada, Eugeni
  • Castellano, Yolanda
  • Saura, Judith
  • Guydish, Joseph
  • Fernández, Esteve
  • Ballbè, Montse
Background and Aim - Hospitalization is an ideal time to promote smoking cessation, but interventions are limited for supporting cessation maintenance after discharge. This study aimed to evaluate the acceptability of participating in a trial that tested the efficacy of an intensive telephone-based intervention for smokers after discharge. Methods - Adult smokers admitted to mental health wards of six hospitals were invited to participate in the trial. We studied the study acceptance/decline rates by analyzing the characteristics of participants (e.g., sex, age, psychiatric disorder, smoking pattern) and hospitals (e.g., size, tobacco control implementation). We calculated adjusted odds ratios (aOR) to assess predictors of non-participation. Results - Of 530 smokers that met the study inclusion criteria, 55.5% (n = 294) agreed to participate. Participant and non-participants were not different in sex, age, or psychiatric diagnosis. Compared to non-participants, participants had made more attempts to quit in the past year (66.1% vs 33.9%; p < 0.001) and reported higher abstinence rates during the hospital stay (66.7% vs. 33.3%; p = 0.05). Participation rates by hospital varied from 30.9% to 82.0% (p < 0.001). Predictors of non-participation were not having attempted to quit in the last year (aOR=2.42; 95%CI: 1.66–3.53) and low level of tobacco control in the hospital (aOR range: 1.79–6.39, p < 0.05). Conclusions - A telephone-based intervention to promote smoking cessation after discharge was accepted by half of the smokers with mental health disorders. Smokers that had attempted to quit previously and those that stayed in hospitals with a strong tobacco control policy were more likely to participate in the trial.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pseudo-nitzschia species on the Catalan coast: characterization and contribution to the current knowledge of the distribution of this genus in the Mediterranean Sea

  • Quijano-Scheggia, Sonia
  • Garcés, Esther
  • Andree, Karl
  • de la Iglesia, Pablo
  • Diogène, Jorge
  • Fortuño, Jose-Manuel
  • Camp, Jordi
Proliferations of the genus Pseudo-nitzschia recur along the Catalan coast (NW Mediterranean) throughout the year. The establishment of 58 clonal cultures facilitated morphological studies with scanning electron microscopy (SEM) and ITS 5.8S rDNA sequence characterization. Moreover, strains of each species were examined with respect to sexual compatibility and toxicity. The results of the morphological and phylogenetic studies confirmed nine species of the genus Pseudo-nitzschia: P. brasiliana, P. calliantha, P. delicatissima clade A/del 2, P. arenysensis, P. fraudulenta, P. galaxiae, P. linea, P. multistriata and P. pungens clade I. Moreover, two Pseudo-nitzschia species, P. caciantha and P. cf mannii, could only be identified following SEM analysis of their morphology. None of the cultured strains of Pseudo-nitzschia analyzed produced domoic acid in amounts above the limit of detection. The current distributions of the Pseudo-nitzschia species in the Mediterranean Sea were plotted on maps, which led to the following observations: i) diversity within this genus is much greater than previously considered, ii) some species have a broad distribution (e.g. P. calliantha), iii) whereas the distribution of others is narrowly restricted (e.g. P. pungens clade I). Moreover, this study reports the first detection of P. linea in the Mediterranean Sea and is the first description of P. galaxiae and P. cf mannii along the Catalan coast. Morphological studies coupled with molecular biological characterization, mating tests and biogeographic distribution analyses provide a critical theoretical basis for testing and/or implementing the current phylogenetic framework in the genus Pseudo-nitzschia., This study was funded by ACA (Generalitat de Catalunya), CSIC, the EC-funded Research Project SEED, GOCE-CT- 2005-003875 and the Programa de seguiment de la qualitat de les aigües, mol.luscs i fitoplancton tòxic a les zones de producció de marisc del litoral català de la DGPIAM and the Xarxa de Referència de Recerca i Desenvolupament en Aqüicultura. IRTA acknowledges financial support from the Instituto Nacional de Investigación Agraria (INIA) through the project RTA2006-00103-00-00. S. Quijano-Scheggia’s work was supported by a PROMEP grant, Universidad de Colima, México. E. Garcés’s work was supported by a Ramon y Cajal contract from the Spanish Ministry of Science and Education., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Bidirectional Photoswitching of a Tailored Azobenzene with Red and Far-Red Light Involving Triplet Sensitization in an Aqueous System

  • Miroshnichenko, Mila
  • Hölzel, Helen
  • Orentas, Edvinas
  • Kazlauskas, Karolis
  • Ferreira, Pedro
  • Dumoulin, Fabienne
  • Alcaide, Carles
  • Solà, Miquel
  • Bresolí-Obach, Roger
  • Nonell, Santi
  • Bharmoria, Pankaj
  • Moth-Poulsen, Kasper
Shifting action spectrum of azobenzene-based photopharmaceuticals toward bio-optical window is highly desired, since red/far-red light offers improved tissue penetration and reduced cellular toxicity. While unidirectional photoswitching (trans-to-cis and cis-to-trans) of azobenzenes (AZO) with red/far-red light is known in separate systems, achieving bidirectional photoswitching in a single system faces issues of spectral overlaps. Here, bidirectional photoswitching of a tailored azobenzene is achieved in a single bio-relevant solution with red and far-red light excitation. A new azobenzene molecule (AZO-N) bearing four ortho-methoxy, and one para-N donor lipophile is synthesized. The AZO-N exhibits separate n-π* absorption bands and triplet energies for trans and cis isomers. As a result, trans-to-cis photoswitching is observed upon 625 nm excitation at the tail of the red-shifted n-π*absorption band via direct absorption, whereas cis-to-trans photoswitching is enabled upon 730 nm excitation through triplet sensitization. Further, triplet sensitization of AZO-based molecules could lead to singlet oxygen generation—experiments in the presence of serum albumin and glutathione (biological oxidative stress addressors), suggest no effect of singlet oxygen on the triplet-sensitization of cis-AZO-N, and non-significant change in the fingerprint all-α secondary structure of serum albumin. This advance presents modular design principles to develop practically functional azo-based photopharmaceuticals., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy

  • Castellví, Marc
  • Felip, Eudald|||0000-0002-3812-1313
  • Ezeonwumelu, I.J.|||0000-0003-4007-2212
  • Badia, Roger|||0000-0003-3982-7577
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Pujantell, Maria|||0000-0002-9471-5853
  • Gutiérrez-Chamorro, Lucía|||0000-0002-7649-951X
  • Teruel, Iris|||0000-0002-5563-6562
  • Martínez Cardús, Anna|||0000-0002-3937-8794
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Margelí, Mireia|||0000-0003-3594-4530
  • Ballana, Ester|||0000-0002-5215-7363
Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 (SAMHD1) is a dNTP triphosphohydrolase involved in the regulation of the intracellular dNTP pool, linked to viral restriction, cancer development and autoimmune disorders. SAMHD1 function is regulated by phosphorylation through a mechanism controlled by cyclin-dependent kinases and tightly linked to cell cycle progression. Recently, SAMHD1 has been shown to decrease the efficacy of nucleotide analogs used as chemotherapeutic drugs. Here, we demonstrate that SAMHD1 can enhance or decrease the efficacy of various classes of anticancer drug, including nucleotide analogues, but also anti-folate drugs and CDK inhibitors. Importantly, we show that selective CDK4/6 inhibitors are pharmacological activators of SAMHD1 that act by inhibiting its inactivation by phosphorylation. Combinations of a CDK4/6 inhibitor with nucleoside or folate antimetabolites potently enhanced drug efficacy, resulting in highly synergic drug combinations (CI < 0.04). Mechanistic analyses reveal that cell cycle-controlled modulation of SAMHD1 function is the central process explaining changes in anticancer drug efficacy, therefore providing functional proof of the potential of CDK4/6 inhibitors as a new class of adjuvants to boost chemotherapeutic regimens. The evaluation of SAMHD1 expression in cancer tissues allowed for the identification of cancer types that would benefit from the pharmacological modulation of SAMHD1 function. In conclusion, these results indicate that the modulation of SAMHD1 function may represent a promising strategy for the improvement of current antimetabolite-based treatments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Secondhand smoke exposure assessment in outdoor hospitality venues across 11 European countries

  • Henderson, Elisabet|||0000-0002-4114-943X
  • Continente, Xavier|||0000-0003-4888-2754
  • Fernández, Esteve|||0000-0003-4239-723X
  • Tigova, Olena|||0000-0002-4002-116X
  • Cortés-Francisco, Nuria|||0000-0002-1627-9718
  • Gallus, Silvano|||0000-0002-8967-0400
  • Lugo, Alessandra|||0000-0002-4297-6496
  • Semple, Sean|||0000-0002-0462-7295
  • Dobson, Ruaraidh|||0000-0001-8136-8373
  • Clancy, Luke|||0000-0003-2407-2263
  • Keogan, Sheila
  • Ruprecht, Ario
  • Borgini, Alessandro|||0000-0002-5167-4297
  • Tzortzi, Anna S|||0000-0003-2420-7922
  • Vyzikidou, Vergina Konstantina
  • Gorini, Giuseppe|||0000-0002-1413-5948
  • López-Nicolás, Ángel|||0000-0003-3112-7779
  • Soriano, Joan B..|||0000-0001-9740-2994
  • Geshanova, Gergana
  • Osman, Joseph
  • Mons, Ute|||0000-0003-1764-6783
  • Przewozniak, Krzysztof
  • Precioso, José|||0000-0002-7889-8290
  • Brad, Ramona
  • López, Maria J.
Due to partial or poorly enforced restrictions secondhand tobacco smoke (SHS) is still present in outdoor hospitality venues in many European countries. This study aimed to assess SHS concentrations in outdoor hospitality venues across Europe and identify contextual exposure determinants. Cross-sectional study. We measured airborne nicotine and evidence of tobacco use in terraces of bars, cafeterias, and pubs from 11 European countries in 2017-2018. Sites were selected considering area-level socioeconomic indicators and half were visited during nighttime. We noted the smell of smoke, presence of smokers, cigarette butts, ashtrays, and number of physical covers. Contextual determinants included national smoke-free policies for the hospitality sector, the Tobacco Control Scale score (2016), and the national smoking prevalence (2017-2018). We computed medians and interquartile ranges (IQR) of nicotine concentrations and used multivariate analyses to characterize the exposure determinants. Nicotine was present in 93.6% of the 220 sites explored. Overall concentrations were 0.85 (IQR:0.30-3.74) μg/m 3 and increased during nighttime (1.45 IQR:0.65-4.79 μg/m 3), in enclosed venues (2.97 IQR:0.80-5.80 μg/m 3), in venues with more than two smokers (2.79 IQR:1.03-6.30 μg/m 3), in venues in countries with total indoor smoking bans (1.20 IQR:0.47-4.85 μg/m 3), and in venues in countries with higher smoking prevalence (1.32 IQR:0.49-5.34 μg/m 3). In multivariate analyses, nicotine concentrations were also positively associated with the observed number of cigarette butts. In venues with more than two smokers, SHS levels did not significantly vary with the venues' degree of enclosure. Our results suggest that current restrictions in outdoor hospitality venues across Europe have a limited protective effect and justify the adoption of total smoking bans in outdoor areas of hospitality venues.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone

  • Estellés, Teresa
  • Zhu, Nuole|||0000-0002-0015-9455
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Subirana, Andrea
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Lehmann, Sylvain|||0000-0001-6117-562X
  • Belbin, Olivia|||0000-0002-6109-6371
  • Blesa, Rafael|||0000-0003-4026-2884
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
Cerebrospinal fluid (CSF) Aβ1-42 levels and the Aβ1-42/Aβ1-40 ratio are markers of amyloid pathology, but previous studies suggest that their levels might be influenced by additional pathophysiological processes. To compare Aβ1-42 and the Aβ1-42/Aβ1-40 ratio in CSF in different neurodegenerative disorders and study their association with other biomarkers (tTau, pTau181, and NfL) and with cognitive and functional progression. We included all participants from the Sant Pau Initiative on Neurodegeneration (SPIN) with CSF Aβ1-42 and Aβ1-42/Aβ1-40. Participants had diagnoses of Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal lobar degeneration-related syndromes, non-neurodegenerative conditions, or were cognitively normal. We classified participants as "positive" or "negative" according to each marker. We compared CSF levels of tTau, pTau181, and NfL between concordant and discordant groups through ANCOVA and assessed differences in cognitive (MMSE, FCSRT) and functional (GDS, CDR-SOB) progression using Cox regression and linear-mixed models. In the 1791 participants, the agreement between Aβ1-42 and Aβ1-42/Aβ1-40 was 78.3%. The Aβ1-42/Aβ1-40 ratio showed a stronger correlation with tTau and pTau181 than Aβ1-42 and an agreement with tTau and pTau181 of 73.1% and 77.1%, respectively. Participants with a low Aβ1-42/Aβ1-40 ratio showed higher tTau and pTau181 and worse cognitive and functional prognosis, regardless of whether they were positive or negative for Aβ1-42. The results were consistent across stages, diagnostic categories, and use of different cutoffs. Although Aβ1-42 and Aβ1-42/Aβ1-40 are considered markers of the same pathophysiological pathway, our findings provide evidence favoring the use of the Aβ1-42/Aβ1-40 ratio in clinical laboratories in the context of AD. The online version contains supplementary material available at 10.1186/s13195-022-00967-z.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir

  • Badia, Roger|||0000-0003-3982-7577
  • Ballana, Ester|||0000-0002-5215-7363
  • Castellví, Marc
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Pujantell, Maria|||0000-0002-9471-5853
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Prado, Julia G.|||0000-0002-5439-4645
  • Puig, Jordi|||0000-0002-4075-0346
  • Martinez, Miguel Angel|||0000-0002-6681-4950
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Este, José|||0000-0002-1436-5823
CD32 has been shown to be preferentially expressed in latently HIV-1-infected cells in an in vitro model of quiescent CD4 T cells. Here we show that stimulation of CD4+ T cells with IL-2, IL-7, PHA, and anti-CD3/CD28 antibodies induces T-cell proliferation, co-expression of CD32 and the activation of the markers HLA-DR and CD69. HIV-1 infection increases CD32 expression. 79.2% of the CD32+/CD4+ T cells from HIV+ individuals under antiretroviral treatment were HLA-DR+. Resting CD4+ T cells infected in vitro generally results in higher integration of provirus. We observe no difference in provirus integration or replication-competent inducible latent HIV-1 in CD32+ or CD32- CD4+ T cells from HIV+ individuals. Our results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals and raises questions regarding the immune resting status of CD32+ cells harboring HIV-1 proviruses. CD32 has been previously shown to be expressed preferentially by CD4 T cells latently harbouring HIV-1. Here the authors show that CD32 expression in CD4 T cells is associated with T cell activation, is up-regulated by HIV-1 infection and importantly does not appear to represent an enriched cellular niche for latent HIV-1.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages

  • Pujantell, Maria|||0000-0002-9471-5853
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Badia, Roger|||0000-0003-3982-7577
  • Castellví, Marc
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Sirera, Guillem|||0000-0003-4014-9355
  • Puig Oliva, Teresa
  • Ramirez Soto, Cristina
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Este, José|||0000-0002-1436-5823
  • Ballana, Ester|||0000-0002-5215-7363
ADAR1-dependent A-to-I editing has recently been recognized as a key process for marking dsRNA as self, therefore, preventing innate immune activation and affecting the development and resolution of immune-mediated diseases and infections. Here, we have determined the role of ADAR1 as a regulator of innate immune activation and modifier of viral susceptibility in primary myeloid and lymphoid cells. We show that ADAR1 knockdown significantly enhanced interferon, cytokine and chemokine production in primary macrophages that function as antiviral paracrine factors, rendering them resistant to HIV-1 infection. ADAR1 knockdown induced deregulation of the RLRs-MAVS signaling pathway, by increasing MDA5, RIG-I, IRF7 and phospho-STAT1 expression, an effect that was partially rescued by pharmacological blockade of the pathway. In summary, our results demonstrate a role of ADAR1 in regulating innate immune function in primary macrophages, suggesting that macrophages may play an essential role in disease associated to ADAR1 dysfunction. We also show that viral inhibition is exclusively dependent on innate immune activation consequence of ADAR1 knockdown, pointing towards ADAR1 as a potential target to boost antiviral immune response.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome

  • Lleó, Alberto|||0000-0002-2568-5478
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Karikari, Thomas K.|||0000-0003-1422-4358
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Montal, Victor|||0000-0002-5714-9282
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Lantero Rodríguez, Juan|||0000-0002-7426-678X
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Benejam, Bessy|||0000-0002-6789-8615
  • Fernández, Susana|||0000-0002-9777-1156
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Garzón, Diana
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Camacho, Valle|||0000-0003-0748-0847
  • Medrano-Martorell, Santiago|||0000-0002-6586-7284
  • Belbin, Olivia|||0000-0002-6109-6371
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Lehmann, Sylvain|||0000-0001-6117-562X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Blesa, Rafael|||0000-0003-4026-2884
  • Blennow, Kaj|||0000-0002-1890-4193
  • Fortea, Juan|||0000-0002-1340-638X
  • Zetterberg, Henrik|||0000-0003-3930-4354
Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology with high accuracy in the general population. In this study, we investigated plasma p-tau181 as a biomarker of AD in individuals with Down syndrome (DS). We included 366 adults with DS (240 asymptomatic, 43 prodromal AD, 83 AD dementia) and 44 euploid cognitively normal controls. We measured plasma p-tau181 with a Single molecule array (Simoa) assay. We examined the diagnostic performance of p-tau181 for the detection of AD and the relationship with other fluid and imaging biomarkers. Plasma p-tau181 concentration showed an area under the curve of 0.80 [95% CI 0.73-0.87] and 0.92 [95% CI 0.89-0.95] for the discrimination between asymptomatic individuals versus those in the prodromal and dementia groups, respectively. Plasma p-tau181 correlated with atrophy and hypometabolism in temporoparietal regions. Our findings indicate that plasma p-tau181 concentration can be useful to detect AD in DS. Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology. Here, the authors investigated whether plasma ptau181 could be a potential biomarker of AD in individuals with Down syndrome (DS) and find plasma p-tau181 can detect AD in DS adults.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

  • Zhu, Nuole|||0000-0002-0015-9455
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Montal, Victor|||0000-0002-5714-9282
  • Estellés, Teresa
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Muñoz, Laia|||0000-0003-0578-3094
  • Belbin, Olivia|||0000-0002-6109-6371
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Subirana, Andrea
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Blesa, Rafael|||0000-0003-4026-2884
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
Background: Astrocytes play an essential role in neuroinflammation and are involved in the pathogenesis of neurodenegerative diseases. Studies of glial fibrillary acidic protein (GFAP), an astrocytic damage marker, may help advance our understanding of different neurodegenerative diseases. In this study, we investigated the diagnostic performance of plasma GFAP (pGFAP), plasma neurofilament light chain (pNfL) and their combination for frontotemporal dementia (FTD) and Alzheimer's disease (AD) and their clinical utility in predicting disease progression. Methods: pGFAP and pNfL concentrations were measured in 72 FTD, 56 AD and 83 cognitively normal (CN) participants using the Single Molecule Array technology. Of the 211 participants, 199 underwent cerebrospinal (CSF) analysis and 122 had magnetic resonance imaging. We compared cross-sectional biomarker levels between groups, studied their diagnostic performance and assessed correlation between CSF biomarkers, cognitive performance and cortical thickness. The prognostic performance was investigated, analyzing cognitive decline through group comparisons by tertile. Results: Unlike pNfL, which was increased similarly in both clinical groups, pGFAP was increased in FTD but lower than in AD (all P < 0.01). Combination of both plasma markers improved the diagnostic performance to discriminate FTD from AD (area under the curve [AUC]: combination 0.78; pGFAP 0.7; pNfL 0.61, all P < 0.05). In FTD, pGFAP correlated with cognition, CSF and plasma NfL, and cortical thickness (all P < 0.05). The higher tertile of pGFAP was associated with greater change in MMSE score and poor cognitive outcome during follow-up both in FTD (1.40 points annually, hazard ratio [HR] 3.82, P < 0.005) and in AD (1.20 points annually, HR 2.26, P < 0.005). Conclusions: pGFAP and pNfL levels differ in FTD and AD, and their combination is useful for distinguishing between the two diseases. pGFAP could also be used to track disease severity and predict greater cognitive decline during follow-up in patients with FTD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Secondhand smoke presence in outdoor areas in 12 European countries

  • Henderson, Elisabet|||0000-0002-4114-943X
  • Lugo, Alessandra|||0000-0002-4297-6496
  • Liu, X.
  • Continente, Xavier|||0000-0003-4888-2754
  • Fernández, Esteve|||0000-0003-4239-723X
  • López Medina, María José|||0000-0003-4402-2239
  • Gallus, Silvano|||0000-0002-8967-0400
Introduction: Secondhand smoke (SHS) causes morbidity and mortality among non-smokers. Objectives: To investigate SHS presence in outdoor areas from 12 European countries and its association with country-level characteristics. Methods: Cross-sectional study performed in 2017-2018 within the TackSHS project. We conducted a face-to-face survey on a representative sample of the population aged 15 years and older from 12 European countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain. Out of 11,902 participants, 8,562 were non-smokers. SHS presence was assessed in selected outdoor areas and defined as respondents viewing someone smoking the last time they visited each setting within the last 6 months. A ranking score for outdoor SHS presence was assigned to each country based on the SHS presence in each setting. We used Spearman's correlation (r) and the Chi-squared tests to assess the relationship between SHS presence and country-level characteristics. Results: Except for children's playgrounds (39.5%; 95% confidence interval, CI: 37.6%-41.3%), more than half of non-smokers reported SHS presence in outdoor areas: schools (52.0%; 95%CI: 50.2%-53.7%), stadia (57.4%; 95%CI: 55.4%-59.4%), parks (67.3%; 95%CI: 66.0%-68.5%), hospitals (67.3%; 95%CI: 65.8%-68.7%), public transport stops (69.9%; 95%CI: 68.6%-71.2%), bar/restaurant terraces (71.4%; 95%CI: 70.2%-72.6%), and beaches (72.8%; 95%CI: 71.4%-74.1%). Residents in Latvia showed the highest overall outdoor SHS presence rank, followed by Greece, and Portugal. Outdoor SHS presence was directly correlated to the country's smoking prevalence (r = 0.64), and inversely correlated to the Tobacco Control Scale 2016 overall score (r = -0.62), the socio-demographic index 2017 (r = -0.56), and Gross Domestic Product per capita 2018 (r = -0.47) (p < 0.001). Conclusions: SHS presence is high in most outdoor areas in Europe, especially in countries with higher smoking prevalence and lower tobacco control performance. To address outdoor SHS exposure, our findings require considering smoking bans along with other strategies to reduce smoking prevalence.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Secondhand smoke exposure in outdoor children's playgrounds in 11 European countries

  • Henderson, Elisabet|||0000-0002-4114-943X
  • Continente, Xavier|||0000-0003-4888-2754
  • Fernández, Esteve|||0000-0003-4239-723X
  • Tigova, Olena|||0000-0002-4002-116X
  • Cortés-Francisco, Nuria|||0000-0002-1627-9718
  • Gallus, Silvano|||0000-0002-8967-0400
  • Lugo, Alessandra|||0000-0002-4297-6496
  • Semple, Sean|||0000-0002-0462-7295
  • O'Donnell, Rachel|||0000-0003-2713-1847
  • Clancy, Luke|||0000-0003-2407-2263
  • Keogan, Sheila
  • Ruprecht, Ario Alberto
  • Borgini, Alessandro|||0000-0002-5167-4297
  • Tzortzi, Anna S.|||0000-0003-2420-7922
  • Vyzikidou, Vergina Konstantina
  • Gorini, Giuseppe|||0000-0002-1413-5948
  • López-Nicolás, Ángel|||0000-0003-3112-7779
  • Soriano, Joan B.|||0000-0001-9740-2994
  • Geshanova, Gergana
  • Osman, Joseph
  • Mons, Ute|||0000-0003-1764-6783
  • Przewozniak, Krzysztof
  • Precioso, José|||0000-0002-7889-8290
  • Brad, Ramona
  • López Medina, María José|||0000-0003-4402-2239
Introduction: Tobacco presence in outdoor children's playgrounds is concerning not only because it leads to secondhand smoke (SHS) exposure, but also cigarette butt pollution and tobacco normalization. Objectives: This study aimed to assess SHS exposure in children's playgrounds, according to area-level socioeconomic status (SES), smoke-free regulations, national smoking prevalence, and SHS exposure prevalence in playgrounds (2017-2018). Methods: We monitored vapor-phase nicotine concentration and tobacco-related variables in 20 different playgrounds in 11 European countries (n = 220 measurements) from March 2017 to April 2018. Playgrounds were selected according to area-level SES. Data on the number of people smoking, and cigarette butts inside the playground and on playground surroundings (<1 m away) were recorded. Playground smoking bans, the Tobacco Control Scale (TCS) score, national smoking prevalence and SHS exposure prevalence in playgrounds were used to group countries. To determine nicotine presence, we dichotomized concentrations using the limit of quantification as a cut-off point (0.06 μg/m). Nicotine median concentrations were compared using non-parametric tests, and nicotine presence and tobacco-related observational variables using the Chi-squared test. Results: Airborne nicotine presence was found in 40.6% of the playgrounds. Median nicotine concentration was <0.06 μg/m (Interquartile range: <0.06-0.125) and higher median concentrations were found in more deprived neighborhoods, non-regulated playgrounds, in countries with lower overall TCS scores, higher national smoking prevalence and higher SHS exposure prevalence in playgrounds. Overall, people were smoking in 19.6% of the playgrounds. More than half of playgrounds had cigarette butts visible inside (56.6%) and in the immediate vicinity (74.4%). Presence of butts inside playgrounds was higher in sites from a low area-level SES, in countries with low TCS scores, and greater smoking prevalence and SHS exposure prevalence (p<0.05). Conclusions: There is evidence of SHS exposure in children's playgrounds across Europe. These findings confirm the need for smoking bans in playgrounds and better enforcement in those countries with smoking bans in playgrounds.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Temperature-controlled switchable photochromism in solid materials

  • Julià López, Àlex|||0000-0002-3357-8349
  • Hernando, Jordi|||0000-0002-1126-4138
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Gonzalez Monje, Pablo|||0000-0001-8781-8574
  • Sedó Vegara, Josep|||0000-0002-4195-7541
  • Roscini, Claudio|||0000-0002-0157-8934
A novel strategy to achieve thermally switchable photochromism in solid materials is reported, which relies on the preparation of polymeric core-shell capsules containing solutions of photochromic dyes in acidic phase-change materials. Upon changing the phase (solid or liquid) of the encapsulated medium, one of the two photochromic states of the system is selectively stabilized on demand, allowing for reversible interconversion between direct and reverse photochromism when thermally scanning through the melting temperature of the phase-change material. This strategy, which does not require the addition of external agents or chemical modification of the dyes, proved to be general for different spiropyran photochromes and to be applicable to the fabrication of a variety of functional materials by simply embedding the capsules obtained into a solid matrix of choice.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Tobacco control policies in the 21st century, achievements and open challenges

  • Peruga, Armando|||0000-0002-1138-3292
  • López Medina, María José|||0000-0003-4402-2239
  • Martínez, Cristina|||0000-0002-9368-1356
  • Fernández, Esteve|||0000-0003-4239-723X
Noncommunicable diseases (NCDs), including cancer, are responsible for almost 70% of all deaths worldwide. Tobacco use is a risk factor common to most NCDs. This article discusses tobacco control policies and highlights major achievements and open challenges to reduce smoking prevalence and attributable morbidity and mortality in the 21st century. The introduction of the WHO Framework Convention on Tobacco Control in 2005 has been a key achievement in the field and has already facilitated a drop in both smoking prevalence and exposure to secondhand smoke. Indicatively, the size of the worldwide population benefiting from at least one cost-effective tobacco control policy has quadrupled since 2007. In addition, plain cigarette packaging has been successfully introduced as a tobacco control policy, surmounting efforts of the tobacco industry to challenge this based on trade and investment law. Nevertheless, tobacco control still faces major challenges. Smoking prevalence needs to be further reduced in a rather expedited manner. Smoke-free environments should be extended, and the use of plain tobacco packaging with large pictorial health warnings for all tobacco products should be further promoted in some parts of the world. Some of these measures will require prompt determination and diligence. For example, bold political decisions are needed to significantly increase real prices of tobacco products through excise taxes, ban added ingredients that are currently used to increase the attractiveness of tobacco products and ban the tobacco industry's corporate social responsibility initiatives. Finally, the debate on harm reduction strategies for tobacco control still needs to be resolved.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Who smokes in europe? Data from 12 european countries in the tackshs survey (2017-2018)

  • Gallus, Silvano|||0000-0002-8967-0400
  • Lugo, Alessandra|||0000-0002-4297-6496
  • Liu, Xiaoqiu|||0000-0001-8620-6592
  • Behrakis, Panagiotis
  • Boffi, Roberto|||0000-0002-1657-1591
  • Bosetti, Cristina|||0000-0003-2090-4608
  • Carreras, Giulia|||0000-0002-1427-637X
  • Chatenoud, Liliane|||0000-0001-9599-8229
  • Clancy, Luke|||0000-0003-2407-2263
  • Continente, Xavier|||0000-0003-4888-2754
  • Dobson, Ruaraidh|||0000-0001-8136-8373
  • Effertz, Tobias
  • Filippidis, Filippos T.
  • Fu, Marcela|||0000-0002-4962-0927
  • Geshanova, Gergana
  • Gorini, Giuseppe|||0000-0002-1413-5948
  • Keogan, Sheila
  • Ivanov, Hristo
  • López Medina, María José|||0000-0003-4402-2239
  • López-Nicolás, Ángel|||0000-0003-3112-7779
  • Precioso, José|||0000-0002-7889-8290
  • Przewozniak, Krzysztof
  • Radu-Loghin, Cornel|||0000-0002-9922-4535
  • Ruprecht, Ario Alberto
  • Semple, Sean|||0000-0002-0462-7295
  • Soriano, Joan B.|||0000-0001-9740-2994
  • Starchenko, Polina
  • Trapero-Bertran, Marta|||0000-0002-9233-1776
  • Tigova, Olena|||0000-0002-4002-116X
  • Tzortzi, Anna S.|||0000-0003-2420-7922
  • Vardavas, Constantine|||0000-0003-0171-9570
  • Vyzikidou, Vergina Konstantina
  • Colombo, Paolo
  • Fernández, Esteve|||0000-0003-4239-723X
Background: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries. Methods: Within the TackSHS Project, a face-to-face survey on smoking was conducted in 2017-2018 in 12 countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain, representing around 80% of the 432 million European Union (EU) adult population. In each country, a representative sample of around 1,000 subjects aged 15 years and older was interviewed, for a total of 11,902 participants. Results: Overall, 25.9% of participants were current smokers (31.0% of men and 21.2% of women, P < 0.001), while 16.5% were former smokers. Smoking prevalence ranged from 18.9% in Italy to 37.0% in Bulgaria. It decreased with increasing age (compared to <45, multivariable odds ratio [OR] for ≥65 year, 0.31; 95% confidence interval [CI], 0.27-0.36), level of education (OR for low vs high, 1.32; 95% CI, 1.17-1.48) and self-rated household economic level (OR for low vs high, 2.05; 95% CI, 1.74-2.42). The same patterns were found in both sexes. Conclusions: These smoking prevalence estimates represent the most up-to-date evidence in Europe. From them, it can be derived that there are more than 112 million current smokers in the EU-28. Lower socio-economic status is a major determinant of smoking habit in both sexes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

  • Boström, Gustaf
  • Freyhult, Eva|||0000-0003-0226-1047
  • Virhammar, Johan|||0000-0001-9901-2949
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Tumani, Hayrettin|||0000-0002-1647-6201
  • Otto, Markus
  • Brundin, Rose-Marie
  • Kilander, Lena
  • Löwenmark, Malin
  • Giedraitis, Vilmantas|||0000-0003-3423-2021
  • Lleó, Alberto|||0000-0002-2568-5478
  • Von Arnim, Christine A.F.
  • Kultima, Kim|||0000-0002-0680-1410
  • Ingelsson, Martin|||0000-0001-5466-8370
Background: Neuroinflammatory processes are common in neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), but current knowledge is limited as to whether cerebrospinal fluid (CSF) levels of neuroinflammatory proteins are altered in these diseases. Objective: To identify and characterize neuroinflammatory signatures in CSF from patients with AD, mild cognitive impairment (MCI), and FTD. Methods: We used proximity extension assay and ANOVA to measure and compare levels of 92 inflammatory proteins in CSF from 42 patients with AD, 29 with MCI due to AD (MCI/AD), 22 with stable MCI, 42 with FTD, and 49 control subjects, correcting for age, gender, collection unit, and multiple testing. Results: Levels of matrix metalloproteinase-10 (MMP-10) were increased in AD, MCI/AD, and FTD compared with controls (AD: Fold change [FC]=1.32, 95% confidence interval [CI] 1.14-1.53, q=0.018; MCI/AD: FC=1.53, 95% CI 1.20-1.94, q=0.045; and FTD: FC=1.42, 95% CI 1.10-1.83, q=0.020). MMP-10 and eleven additional proteins were increased in MCI/AD, compared with MCI (q<0.05). In FTD, 36 proteins were decreased, while none was decreased in AD or MCI/AD, compared with controls (q<0.05). Conclusion: In this cross-sectional multi-center study, we found distinct patterns of CSF inflammatory marker levels in FTD and in both early and established AD, suggesting differing neuroinflammatory processes in the two disorders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Use and Awareness of Heated Tobacco Products in Europe

  • Gallus, Silvano|||0000-0002-8967-0400
  • Lugo, Alessandra|||0000-0002-4297-6496
  • Liu, Xiaoqiu|||0000-0001-8620-6592
  • Borroni, Elisa
  • Clancy, Luke|||0000-0003-2407-2263
  • Gorini, Giuseppe|||0000-0002-1413-5948
  • López Medina, María José|||0000-0003-4402-2239
  • Odone, Anna
  • Przewozniak, Krzysztof
  • Tigova, Olena|||0000-0002-4002-116X
  • van den Brandt, Piet A.
  • Vardavas, Constantine|||0000-0003-0171-9570
  • Fernández, Esteve|||0000-0003-4239-723X
Background: Heated tobacco products (HTP) are new forms of tobacco consumption with limited information available on their use among the general population. Our objective was to analyze the prevalence and associations of use of HTP across 11 countries in Europe. Methods: Within the TackSHS Project, in 2017-2018 we conducted a cross-sectional study with information on HTP use in the following countries: Bulgaria, England, France, Germany, Greece, Italy, Latvia, Poland, Portugal, Romania and Spain. In each country, face-to-face interviews were performed on a representative sample of around 1,000 subjects aged ≥15 years, for a total of 10,839 subjects. Results: Overall, 27.8% of study participants were aware of HTPs, 1.8% were ever HTP users (ranging from 0.6% in Spain to 8.3% in Greece), and 0.1% were current users. Men were more frequently HTP ever users than women (adjusted odds ratio [aOR] 1.47; 95% confidence interval [CI], 1.11-1.95). Ever HTP use was inversely related to age (P for trend <0.001) and more frequent in ex-smokers (compared with never smokers, aOR 4.32; 95% CI, 2.69-6.95) and current smokers (aOR 8.35; 95% CI, 5.67-12.28), and in electronic cigarette past users (compared with never users, aOR 5.48; 95% CI, 3.46-8.68) and current users (aOR 5.92; 95% CI, 3.73-9.40). Conclusions: In 2017-2018, HTP use was still limited in Europe among the general population; however, the dual use of these products, their high use among younger generations, and the interest of non-smokers in these products are worrying and indicate the need for close monitoring in terms of prevalence and the characteristics of users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Correction, Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

  • Zhu, Nuole|||0000-0002-0015-9455
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Montal, Victor|||0000-0002-5714-9282
  • Estellés, Teresa
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Muñoz, Laia|||0000-0003-0578-3094
  • Belbin, Olivia|||0000-0002-6109-6371
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Subirana, Andrea
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Blesa, Rafael|||0000-0003-4026-2884
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
Astrocytes play an essential role in neuroinflammation and are involved in the pathogenesis of neurodenegerative diseases. Studies of glial fibrillary acidic protein (GFAP), an astrocytic damage marker, may help advance our understanding of different neurodegenerative diseases. In this study, we investigated the diagnostic performance of plasma GFAP (pGFAP), plasma neurofilament light chain (pNfL) and their combination for frontotemporal dementia (FTD) and Alzheimer's disease (AD) and their clinical utility in predicting disease progression. pGFAP and pNfL concentrations were measured in 72 FTD, 56 AD and 83 cognitively normal (CN) participants using the Single Molecule Array technology. Of the 211 participants, 199 underwent cerebrospinal (CSF) analysis and 122 had magnetic resonance imaging. We compared cross-sectional biomarker levels between groups, studied their diagnostic performance and assessed correlation between CSF biomarkers, cognitive performance and cortical thickness. The prognostic performance was investigated, analyzing cognitive decline through group comparisons by tertile. Unlike pNfL, which was increased similarly in both clinical groups, pGFAP was increased in FTD but lower than in AD (all P < 0.01). Combination of both plasma markers improved the diagnostic performance to discriminate FTD from AD (area under the curve [AUC]: combination 0.78; pGFAP 0.7; pNfL 0.61, all P < 0.05). In FTD, pGFAP correlated with cognition, CSF and plasma NfL, and cortical thickness (all P < 0.05). The higher tertile of pGFAP was associated with greater change in MMSE score and poor cognitive outcome during follow-up both in FTD (1.40 points annually, hazard ratio [HR] 3.82, P < 0.005) and in AD (1.20 points annually, HR 2.26, P < 0.005). pGFAP and pNfL levels differ in FTD and AD, and their combination is useful for distinguishing between the two diseases. pGFAP could also be used to track disease severity and predict greater cognitive decline during follow-up in patients with FTD. The online version contains supplementary material available at 10.1186/s40035-021-00275-w.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration

  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Nigro, Salvatore
  • Vandevrede, Lawren
  • Falgàs, Neus|||0000-0002-3404-2765
  • Heuer, Hilary W.
  • Painous, Cèlia|||0000-0002-7027-3093
  • Compta, Yaroslau|||0000-0001-6443-0104
  • Martí Domenech, Maria Josep|||0000-0002-9872-7835
  • Montal, Victor|||0000-0002-5714-9282
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Logroscino, Giancarlo|||0000-0003-0423-3242
  • Quattrone, Andrea
  • Perry, David C.
  • Gorno-Tempini, Maria Luisa
  • Rosen, Howard J.|||0000-0001-9281-7402
  • Grinberg, Lea T.
  • Spina, Salvatore
  • La Joie, Renaud
  • Rabinovici, Gil D.
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Rojas, Julio C.|||0000-0002-1308-646X
  • Seeley, William W.
  • Boxer, Adam
Importance: The accurate diagnosis of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) is hampered by imperfect clinical-pathological correlations. Objective: To assess and compare the diagnostic value of the magnetic resonance parkinsonism index (MRPI) and other magnetic resonance imaging-based measures of cerebral atrophy to differentiate between PSP, CBD, and other neurodegenerative diseases. Design, Setting, and Participants: This prospective diagnostic study included participants with 4-repeat tauopathies (4RT), PSP, CBD, other neurodegenerative diseases and available MRI who appeared in the University of California, San Francisco, Memory and Aging Center database. Data were collected from October 27, 1994, to September 29, 2019. Data were analyzed from March 1 to September 14, 2021. Main Outcomes and Measures: The main outcome of this study was the neuropathological diagnosis of PSP or CBD. The clinical diagnosis at the time of the MRI acquisition was noted. The imaging measures included the MRPI, cortical thickness, subcortical volumes, including the midbrain, pons, and superior cerebellar peduncle volumes. Multinomial logistic regression models (MLRM) combining different cortical and subcortical regions were defined to discriminate between PSP, CBD, and other pathologies. The areas under the receiver operating characteristic curves (AUROC) and cutoffs were calculated to differentiate between PSP, CBD, and other diseases. Results: Of the 326 included participants, 176 (54%) were male, and the mean (SD) age at MRI was 64.1 (8.0) years. The MRPI showed good diagnostic accuracy for the differentiation between PSP and all other pathologies (accuracy, 87%; AUROC, 0.90; 95% CI, 0.86-0.95) and between 4RT and other pathologies (accuracy, 80%; AUROC, 0.82; 95% CI, 0.76-0.87), but did not allow the discrimination of participants with CBD. Its diagnostic accuracy was lower in the subgroup of patients without the canonical PSP-Richardson syndrome (PSP-RS) or probable corticobasal syndrome (CBS) at MRI. MLRM combining cortical and subcortical measurements showed the highest accuracy for the differentiation between PSP and other pathologies (accuracy, 95%; AUROC, 0.98; 95% CI, 0.97-0.99), CBD and other pathologies (accuracy, 83%; AUROC, 0.86; 95% CI, 0.81-0.91), 4RT and other pathologies (accuracy, 89%; AUROC, 0.94; 95% CI, 0.92-0.97), and PSP and CBD (accuracy, 91%; AUROC, 0.95; 95% CI, 0.91-0.99), even in participants without PSP-RS or CBS at MRI. Conclusions and Relevance: In this study, the combination of widely available cortical and subcortical measures of atrophy on MRI discriminated between PSP, CBD, and other pathologies and could be used to support the diagnosis of 4RT in clinical practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cortical microstructure in primary progressive aphasia, a multicenter study

  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Montal, Victor|||0000-0002-5714-9282
  • Borrego-Écija, Sergi|||0000-0003-2557-0010
  • Mandelli, Maria Luisa|||0000-0002-2518-2520
  • Falgàs, Neus|||0000-0002-3404-2765
  • Welch, Ariane E.
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Belbin, Olivia|||0000-0002-6109-6371
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Bargalló, Núria|||0000-0001-6284-5402
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Blesa, Rafael|||0000-0003-4026-2884
  • Dickerson, Bradford C.
  • Rosen, Howard J.|||0000-0001-9281-7402
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Lleó, Alberto|||0000-0002-2568-5478
  • Gorno-Tempini, Maria Luisa
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Fortea, Juan|||0000-0002-1340-638X
Background: Cortical mean diffusivity is a novel imaging metric sensitive to early changes in neurodegenerative syndromes. Higher cortical mean diffusivity values reflect microstructural disorganization and have been proposed as a sensitive biomarker that might antedate macroscopic cortical changes. We aimed to test the hypothesis that cortical mean diffusivity is more sensitive than cortical thickness to detect cortical changes in primary progressive aphasia (PPA). Methods: In this multicenter, case-control study, we recruited 120 patients with PPA (52 non-fluent, 31 semantic, and 32 logopenic variants; and 5 GRN-related PPA) as well as 89 controls from three centers. The 3-Tesla MRI protocol included structural and diffusion-weighted sequences. Disease severity was assessed with the Clinical Dementia Rating scale. Cortical thickness and cortical mean diffusivity were computed using a surface-based approach. Results: The comparison between each PPA variant and controls revealed cortical mean diffusivity increases and cortical thinning in overlapping regions, reflecting the canonical loci of neurodegeneration of each variant. Importantly, cortical mean diffusivity increases also expanded to other PPA-related areas and correlated with disease severity in all PPA groups. Cortical mean diffusivity was also increased in patients with very mild PPA when only minimal cortical thinning was observed and showed a good correlation with measures of disease severity. Conclusions: Cortical mean diffusivity shows promise as a sensitive biomarker for the study of the neurodegeneration-related microstructural changes in PPA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Characteristics of subjective cognitive decline associated with amyloid positivity

  • Janssen, Olin|||0000-0002-8341-0958
  • Jansen, Willemijn J.
  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • Boada, Mercè|||0000-0003-2617-3009
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Gabryelewicz, Tomasz
  • Fladby, Tormod|||0000-0002-9984-9797
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Villeneuve, Sylvia
  • Hort, Jakub|||0000-0002-1080-3726
  • Epelbaum, Stéphane
  • Lleó, Alberto|||0000-0002-2568-5478
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Landau, Susan
  • Popp, Julius|||0000-0002-0068-0312
  • Wallin, Anders|||0000-0001-9506-0513
  • Scheltens, Philip|||0000-0002-1046-6408
  • Rikkert, Marcel Olde|||0000-0003-1397-1677
  • Snyder, Peter J.|||0000-0003-0555-4654
  • Rowe, Chris
  • Chételat, G.|||0000-0002-4889-7932
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Marquié, Marta|||0000-0002-0660-0950
  • Chipi, Elena
  • Wolfsgruber, Steffen
  • Heneka, Michael|||0000-0003-4996-1630
  • Boecker, Henning|||0000-0003-2346-0598
  • Peters, Oliver|||0000-0003-0568-2998
  • Jarholm, Jonas
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Pichet Binette, Alexa|||0000-0001-5218-3337
  • Poirier, Judes
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Cerman, Jiri
  • Dubois, Bruno
  • Teichmann, Marc
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Ebenau, Jarith
  • Pocnet, Cornelia
  • Eckerström, Marie
  • Thompson, Louisa
  • Villemagne, Victor
  • Buckley, Rachel|||0000-0002-5356-5537
  • Burnham, Samantha
  • Delarue, Marion
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Wallin, Åsa K.
  • Ramakers, Inez
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Hampel, Harald
  • Spiru, Luiza
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Ossenkoppele, Rik
  • Verhey, Frans
  • Jessen, Frank
  • Visser, Pieter Jelle|||0000-0001-8008-9727
Introduction: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods: In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Results: Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Discussion: Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reducing charge noise in quantum dots by using thin silicon quantum wells

  • Paquelet Wuetz, Brian
  • Degli Esposti, Davide
  • Zwerver, Anne-Marije J.
  • Amitonov, Sergey V.
  • Botifoll, Marc|||0000-0002-4876-6393
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Vandersypen, Lieven M. K.|||0000-0003-4346-7877
  • Russ, Maximilian|||0000-0001-9775-0323
  • Scappucci, Giordano|||0000-0003-2512-0079
Charge noise in the host semiconductor degrades the performance of spin-qubits and poses an obstacle to control large quantum processors. However, it is challenging to engineer the heterogeneous material stack of gate-defined quantum dots to improve charge noise systematically. Here, we address the semiconductor-dielectric interface and the buried quantum well of a 28 Si/SiGe heterostructure and show the connection between charge noise, measured locally in quantum dots, and global disorder in the host semiconductor, measured with macroscopic Hall bars. In 5 nm thick 28 Si quantum wells, we find that improvements in the scattering properties and uniformity of the two-dimensional electron gas over a 100 mm wafer correspond to a significant reduction in charge noise, with a minimum value of 0.29 ± 0.02 μeV/Hz ½ at 1 Hz averaged over several quantum dots. We extrapolate the measured charge noise to simulated dephasing times to -gate fidelities that improve nearly one order of magnitude. These results point to a clean and quiet crystalline environment for integrating long-lived and high-fidelity spin qubits into a larger system. Charge noise degrades the performance of spin qubits hindering scalability. Here the authors engineer the heterogeneous material stack in 28 Si/SiGe gate-defined quantum dots, to improve the scattering properties and to reduce charge noise.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low disorder and high valley splitting in silicon

  • Degli Esposti, Davide
  • Stehouwer, Lucas E.A.
  • Gül, Önder|||0000-0002-3116-4054
  • Samkharadze, Nodar
  • Déprez, Corentin|||0000-0002-6211-0307
  • Meyer, Marcel|||0000-0002-7832-5927
  • Meijer, Ilja N.|||0000-0003-0516-8446
  • Tryputen, Larysa
  • Karwal, Saurabh
  • Botifoll, Marc|||0000-0002-4876-6393
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Amitonov, Sergey V.
  • Vandersypen, Lieven M. K.|||0000-0003-4346-7877
  • Sammak, Amir
  • Veldhorst, Menno|||0000-0001-9730-3523
  • Scappucci, Giordano|||0000-0003-2512-0079
The electrical characterisation of classical and quantum devices is a critical step in the development cycle of heterogeneous material stacks for semiconductor spin qubits. In the case of silicon, properties such as disorder and energy separation of conduction band valleys are commonly investigated individually upon modifications in selected parameters of the material stack. However, this reductionist approach fails to consider the interdependence between different structural and electronic properties at the danger of optimising one metric at the expense of the others. Here, we achieve a significant improvement in both disorder and valley splitting by taking a co-design approach to the material stack. We demonstrate isotopically purified, strained quantum wells with high mobility of 3.14(8) × 10 cm V s and low percolation density of 6.9(1) × 10 cm. These low disorder quantum wells support quantum dots with low charge noise of 0.9(3) μeV Hz and large mean valley splitting energy of 0.24(7) meV, measured in qubit devices. By striking the delicate balance between disorder, charge noise, and valley splitting, these findings provide a benchmark for silicon as a host semiconductor for quantum dot qubits. We foresee the application of these heterostructures in larger, high-performance quantum processors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

  • Guillén, Núria|||0000-0002-1341-9834
  • Contador, José
  • Buongiorno, Mariateresa
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Culell, Natalia
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Piñol-Ripoll, Gerard
  • Carnes-Vendrell, Anna
  • Ispierto, María Lourdes|||0000-0002-1837-9675
  • Vilas Rolán, Dolores|||0000-0003-3084-053X
  • Puig-Pijoan, Albert|||0000-0002-9848-3711
  • Fernández-Lebrero, Aida|||0000-0002-2097-4430
  • Balasa, Mircea|||0000-0002-1795-4228
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
Core Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers have shown incomplete agreement with amyloid-positron emission tomography (PET). Our goal was to analyze the agreement between AD CSF biomarkers and amyloid-PET in a multicenter study. Retrospective multicenter study (5 centers). Participants who underwent both CSF biomarkers and amyloid-PET scan within 18 months were included. Clinical diagnoses were made according to latest diagnostic criteria by the attending clinicians. CSF Amyloid Beta (Aβ, A), phosphorliated tau 181 (pTau181, T) and total tau (tTau, N) biomarkers were considered normal (-) or abnormal (+) according to cutoffs of each center. Amyloid-PET was visually classified as positive/negative. Agreement between CSF biomarkers and amyloid-PET was analyzed by overall percent agreement (OPA). 236 participants were included (mean age 67.9 years (SD 9.1), MMSE score 24.5 (SD 4.1)). Diagnoses were mild cognitive impairment or dementia due to AD (49%), Lewy body dementia (22%), frontotemporal dementia (10%) and others (19%). Mean time between tests was 5.1 months (SD 4.1). OPA between single CSF biomarkers and amyloid-PET was 74% for , 75% for pTau181, 73% for tTau. The use of biomarker ratios improved OPA: 87% for Aβ/Aβ (n = 155), 88% for pTau181/Aβ (n = 94) and 82% for tTau/Aβ (n = 160). A + T + N + cases showed the highest agreement between CSF biomarkers and amyloid-PET (96%), followed by A-T-N- cases (89%). Aβ/Aβ was a better marker of cerebral amyloid deposition, as identified by amyloid tracers, than Aβ alone. Combined biomarkers in CSF predicted amyloid-PET result better than single biomarkers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Enhanced Oxygen Evolution and Zinc-Air Battery Performance via Electronic Spin Modulation in Heterostructured Catalysts

  • Yang, Linlin|||0009-0006-9953-5698
  • He, Ren|||0000-0003-3712-5539
  • Botifoll, Marc|||0000-0002-4876-6393
  • Zhang, Yongcai|||0000-0003-1551-754X
  • Ding, Yang
  • Di, Chong
  • He, Chuansheng
  • Xu, Ying
  • Balcells i Argemí, Lluís|||0000-0001-6603-7357
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Zhou, Yingtang|||0000-0002-8678-295X
  • Cabot i Codina, Andreu|||0000-0002-7533-3251
Beyond optimizing electronic energy levels, the modulation of the electronic spin configuration is an effective strategy, often overlooked, to boost activity and selectivity in a range of catalytic reactions, including the oxygen evolution reaction (OER). This electronic spin modulation is frequently accomplished using external magnetic fields, which makes it impractical for real applications. Herein, spin modulation is achieved by engineering Ni/MnFeO heterojunctions, whose surface is reconstructed into NiOOH/MnFeOOH during the OER. NiOOH/MnFeOOH shows a high spin state of Ni, which regulates the OH and O adsorption energy and enables spin alignment of oxygen intermediates. As a result, NiOOH/MnFeOOH electrocatalysts provide excellent OER performance with an overpotential of 261 mV at 10 mA cm. Besides, rechargeable zinc-air batteries based on Ni/MnFeO show a high open circuit potential of 1.56 V and excellent stability for more than 1000 cycles. This outstanding performance is rationalized using density functional theory calculations, which show that the optimal spin state of both Ni active sites and oxygen intermediates facilitates spin-selected charge transport, optimizes the reaction kinetics, and decreases the energy barrier to the evolution of oxygen. This study provides valuable insight into spin polarization modulation by heterojunctions enabling the design of next-generation OER catalysts with boosted performance.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Association of blood-based DNA methylation markers with late-onset alzheimer disease: a potential diagnostic approach

  • Acha Santamaría, Blanca
  • Corroza, Jon
  • Sánchez Ruiz de Gordoa, Javier
  • Cabello, Carolina
  • Robles Solano, Maitane
  • Méndez López, Iván
  • Macías, Mónica
  • Zueco, Sara
  • Roldán, Miren
  • Urdánoz Casado, Amaya
  • Jericó Pascual, Ivonne
  • Erro Aguirre, María Elena
  • Alcolea, Daniel
  • Lleo, Alberto
  • Blanco Luquin, Idoia
  • Mendióroz Iriarte, Maite
Background and Objectives: There is an urgent need to identify novel noninvasive biomarkers for Alzheimer disease (AD) diagnosis. Recent advances in blood-based measurements of phosphorylated tau (pTau) species are promising but still insufficient to address clinical needs. Epigenetics has been shown to be helpful to better understand AD pathogenesis. Epigenetic biomarkers have been successfully implemented in other medical disciplines, such as oncology. The objective of this study was to explore the diagnostic accuracy of a blood-based DNA methylation marker panel as a noninvasive tool to identify patients with late-onset Alzheimer compared with age-matched controls. Methods: A case-control study was performed. Blood DNA methylation levels at 46 cytosine-guanine sites (21 genes selected after a comprehensive literature search) were measured by bisulfite pyrosequencing in patients with “probable AD dementia” following National Institute on Aging and the Alzheimer's Association guidelines (2011) and age-matched and sex-matched controls recruited at Neurology Department-University Hospital of Navarre, Spain, selected by convenience sampling. Plasma pTau181 levels were determined by Simoa technology. Multivariable logistic regression analysis was performed to explore the optimal model to discriminate patients with AD from controls. Furthermore, we performed a stratified analysis by sex. Results: The final study cohort consisted of 80 patients with AD (age: median [interquartile range] 79 [11] years; 58.8% female) and 100 cognitively healthy controls (age 77 [10] years; 58% female). A panel including DNA methylation levels at NXN, ABCA7, and HOXA3 genes and plasma pTau181 significantly improved (area under the receiver operating characteristic curve 0.93, 95% CI 0.89–0.97) the diagnostic performance of a single pTau181-based model, adjusted for age, sex, and APOE ɛ4 genotype. The sensitivity and specificity of this panel were 83.30% and 90.00%, respectively. After sex-stratified analysis, HOXA3 DNA methylation levels showed consistent association with AD. Discussion: These results highlight the potential translational value of blood-based DNA methylation biomarkers for noninvasive diagnosis of AD. Registration Information: Research Ethics Committee of the University Hospital of Navarre (PI17/02218)., Spanish Government through grants from the Institute of Health Carlos III (FIS PI17/02218), jointly funded by the European Regional Development Fund (ERDF), European Union, A way of shaping Europe; the Department of Industry of Government of Navarra (PI058 iBEAS-Plus and PI055 iBEAS-Plus); Institute of Health Carlos III (FIS PI20/01330 and AC19/00103 to AL) and CIBERNED (Program 1, Alzheimer Disease). The project leading to these results has received funding from la Caixa Foundation (ID 100010434) co-funded by Fundación Luzón (HR20-01109_BIOP-AD) under the project code LCF/PR/PR15/51100006.